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Abstract

BREATHE IN BREATHE OUT…. NOW WHAT?
IMPROVED PEDIATRIC ASTHMA OUTCOMES THROUGH IMPROVED
INHALER TECHNIQUE

Gina M Nickels-Nelson

Scholarly Project Chair: Sandra Petersen, DNP

The University of Texas at Tyler
May 2019

Asthma is a chronic disease affecting families in the United States; especially
pediatric patients aged 5-18. In Pittsfield, Massachusetts the local prevalence of asthma
is 14.4% versus 12.1% statewide and 8.4% nationally. These patients miss school days
thus causing parental workday loss. In 2016, 14.4 million missed school days occurred
due to asthma (Alexander et al., 2016). Unexpected clinic visits, as well as emergency
room visits due to asthma, can contribute to rising healthcare costs both locally and
nationally. Unexpected asthma visits are a leading reason for visits to this author’s clinic.
Asthma is treated with inhaled medications through a metered dose inhaler.
Proper use of this device is imperative for patients to achieve the best asthma control.
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Research has demonstrated that a lack of proper education and teaching of how to use an
inhaler results in less than optimal outcomes. Furthermore, a review of the evidence
indicated that most patients do not correctly utilize an inhaler, confirming that this leads
to decreased medicine effectiveness and poor patient outcomes. At the author’s clinic,
verbal inhaler technique education is provided but was not measured for effectiveness.
The Evidence-Based Practice process guided the Doctor of Nursing scholarly
project. This project was solidly based on existing evidence to support improved
outcomes in the asthma population. Therefore, the question arose, in pediatric patients
with asthma, how does the addition of hands-on inhaler education compared to only
verbal inhaler education affect inhaler technique, appropriate utilization of medications,
clinic exacerbation visits, ER utilization, school attendance, and parent work attendance
over a 3-month period of time?
Based on the evidence, the fundamental component of the scholarly project was to
provide education to healthcare professionals so that they knew proper inhaler use and
how to teach inhaler technique to patients. Following training of healthcare
professionals, a protocol to consistently educate patients on correct inhaler technique was
initiated. Planned outcomes for this project were improved inhaler technique and
tightened asthma control. Outcomes that were planned but were unable to be measured
were asthma exacerbation visits to both clinic and emergency room and missed school
and parental work days. To evaluate these outcomes properly, ongoing quality
improvement methods will be used. Sustainability of the Breathe In-Breathe-Out…Now
What program will be contingent upon addressing lessons learned during the three
months protocol implementation (Summer-Fall of 2018).

vii

Keywords: Evidence-Based Practice Improvement, EBP, Inhaler Technique, Pediatric
Asthma, Asthma Control, School Absence, Parental Work Absence, Emergency Room
Utilization
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Chapter 1: Development of the Clinical Question and Problem Identification
Background and Significance of the Clinical Issue
Asthma is a chronic disease affecting families in the United States; especially
pediatric patients: 868,000 of these visits were for asthma (CDC, 2018). Exacerbations
of asthma resulted in 200,000 hospitalizations and 14.4 million school absences in 2016
(Alexander et al., 2016). An average of 4.1 missed school days occurs with each episode
of asthma exacerbation (Kouba et al., 2012). The total economic impact of missed days
from school, parental work days and total medical costs related to asthma can be close to
56 billion dollars per year (Alexander et al., 2016). Care expenditure for an uncontrolled
case of asthma is more than double that of a controlled asthmatic patient’s care (Price et
al., 2013). Asthma affects all ages, race and socioeconomic levels in the United States.
The Northeast region of the United States has one of the highest incidences of
asthma, with Massachusetts being the highest in the area (Massachusetts Department of
Public Health Asthma Prevention and Control Program, 2009). The Massachusetts
Environmental Public Health Tracking system tracks asthma data from all in-state public,
private and charter schools. From this tracking system, the prevalence rate of asthma has
increased from 11.5% in 2010 to 12.1% for the 2016-2017 school year (Massachusetts
Environmental Public Health Tracking, 2018).
This Scholarly Project took place at Community Health Programs-Berkshire
Pediatric Associates (CHP-BPA) in Pittsfield, Massachusetts. One of ten locations
within the federally qualified health center, this office provided pediatric primary health
care to all patients. Pittsfield is in Berkshire County, which is the westernmost and
second most rural county of Massachusetts. Our clinic is not able to accurately report full
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asthma information due to an electronic medical record (EMR) that does not have a
sophisticated reporting module. However, one can examine Berkshire County and
Pittsfield’s asthma prevalence. The county’s asthma prevalence is slightly lower than the
state, with 10.4% in 2010, rising to 12.2% in 2017 (Massachusetts Environmental Public
Health Tracking, 2018). The rise across the seven years was three times as high in
Berkshire County as it was in the Commonwealth of Massachusetts (1.8% increase
compared to 0.6% increase) (Massachusetts Environmental Public Health Tracking,
2017). Figures AA1-3 in Appendix A display the asthma prevalence rates.
Providers at CHP-BPA care for 45% of the pediatric population in Pittsfield and
surrounding areas. The rise in asthma prevalence in the city from 2010-2017 was 11.8%
to 14.4%; with an increase as high as 16.8% in 2016. Both the prevalence rate and the
rise across the seven years (2.6%) are higher than those for both the county and the state
(Massachusetts Environmental Public Health Tracking, 2018). These data indicate that
this population requires further assessment and possible intervention to reduce the
prevalence and mitigate the additional rise in asthma cases. Figure AA3 in Appendix A
displays these graphics.
Development of the Clinical Question and Problem
As a chronic lung disease, patients respond differently to the treatment and the
condition of asthma itself. Some may only require infrequent therapy for their asthma,
while other patients may progressively require increased medications as well as further
patient care, such as hospitalization. When an asthma exacerbation occurs, swelling and
constriction of the lung musculature follow. Symptoms can include coughing and
wheezing. More severe symptoms can lead to increased difficulty with breathing and
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even death. With these exacerbations, additional provider visits occur; often in the
emergency department. One exacerbation office visit-or emergency department visit
equates to uncontrolled asthma. Uncontrolled asthma occurs when current treatment
(education or medication) does not stop asthma symptoms (Alexander et al., 2016; Kouba
et al., 2012).
Uncontrolled asthma is not an unusual occurrence for the pediatric population in
this country. In Massachusetts, almost 47% of the population had poorly controlled
asthma (Massachusetts Department of Public Health Asthma Prevention and Control
Program, 2009). In 2015, a retrospective chart review took place to evaluate the causal
factors of uncontrolled asthma. These factors included poor metered dose inhaler (MDI)
technique, poor compliance with treatment, exposures to environmental triggers, and comorbid conditions. Only 2.8% of the children had treatment-resistant asthma (deGroot et
al., 2015).
Uncontrolled asthma leads to increased emergency room usage. In 2012,
Massachusetts had 73.08 per 1,000 age-adjusted emergency room visits. Berkshire
County had 86.41 per 1,000 age-adjusted asthma-related emergency room visits and had
the fifth highest asthmatic emergency visit rate in the state. Pittsfield, Massachusetts has
an even higher age-adjusted asthmatic emergency room rate of 121.15 per 1,000 visits
further supporting the need for assessment and intervention (Massachusetts Department
of Public Health Asthma Prevention and Control Program, 2009; Massachusetts
Environmental Public Health Tracking, 2018). Additional costs for asthmatic emergency
room visits or hospitalizations can be incurred since Berkshire County does not have a
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Pediatric Intensive Care Unit (PICU). Critically ill children must be transported to
Baystate Medical Center in Springfield, Massachusetts.
Uncontrolled asthma also leads to decreased school attendance and parental work
attendance. 14.4 million school absences occurred nationally in 2016. An average of 4.1
school days is missed with each asthma exacerbation (Alexander et al., 2016; Kouba et
al., 2012), which also impacts parental work days lost. 41.1% of asthmatic
Massachusetts school students missed at least one day of school in 2010 (Mass.gov,
2018). Nighttime symptoms often occur. With only 1-3 nighttime awakenings due to
symptoms, asthmatic children are nearly four times more likely to miss school compared
to their counterparts. Uncontrolled asthma is also seen in children with learning
difficulties and lower standardized testing scores. Nearly 30% of parents with children
who have uncontrolled asthma reported lost work days due to asthma exacerbations
(Schmier et al., 2006). Pittsfield’s school district has a yearly tuition amount reported for
students. These amounts are $12,928 for elementary; $12,939 for middle school; and
$13,035 for high school students (Pittsfield public schools FY 2018 tuition rates, 2018).
One day missed from school then equates to 71-72 dollars per day just in tuition funds.
The healthcare dollar burden in the United States translates into 200,000
hospitalizations and 868,000 ER visits (Alexander et al., 2016; CDC.gov, 2015
Emergency Department Summary Tables, 2015). The Asthma Prevention and Control
Program in Massachusetts estimates of those children with asthma, 66.2% had
uncontrolled asthma as of 2010. The program states 2010 is the most up to date
information due to small sample sizes with current sampling measures (Mass.gov, 2018).
With uncontrolled asthma, healthcare expenditure per case is more than double the cost
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as compared to a patient with controlled asthma (Price et al., 2012). The cost of inpatient
hospitalized asthma care increased from 57 million dollars in 2002 to 104 million dollars
in 2013 with public insurance (Medicaid, Medicare, and other state programs) the
expected payers of these costs (Mass.gov, 2018).
Mortality due to uncontrolled asthma remains a threat in the pediatric population.
Death is preventable in almost every case of asthma if correct diagnosis, management,
and treatment at home occur. Between 1990 and 2006, 1,708 deaths occurred due to
asthma. This number represents a 63.8% mortality rate decrease over these years. In
2006, 45 deaths took place between the ages of 0-24 in Massachusetts and 219 deaths
nationally in 2015 (CDC, 2018; Mass.gov, 2018).
Inhaled medications are the primary forms of treatment for asthma. A metereddose inhaler (MDI) is utilized to administer these medications. The MDI is the preferred
method of medication delivery with asthma. Inhaled medication is delivered directly to
the lungs, thus, requiring a lower dosage, more rapid onset of action, and decreased
systemic medication amounts (Capanoglu et al., 2015; Manriquez, Acuna, Munoz &
Reyes, 2015; Pedersen, Dubos, & Crompton, 2010). Bronchodilators, or rescue
medications (i.e., pro-air, Ventolin) are fast-acting medications that quickly relieve
inflammation in the lung airways to alleviate symptoms- wheeze, cough and improved
ability to breathe. Inhaled corticosteroids are controller medications (i.e., Flovent, q-var).
As the name implies, the function of corticosteroids is to aid in decreasing inflammation
in the lung airways to reduce asthma symptoms- and to reduce the need for rescue
bronchodilator use.
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Most patients who utilize an MDI are unable to do so effectively (Burkhart,
Rayens, & Bowman, 2005; Carpenter et al., 2015; Janssen, Spoelstra, & Brueren, 2003;
Kamps, VanEwjik, Roorda, & Brand, 2000); however, most patients and families assume
their technique is correct (Alexander et al., 2016; Burkhart et al., 2005; Capanoglu et al.,
2015; Carpenter et al., 2015; Foland et al., 2002; Kamps et al., 2000; Sleath et al., 2012).
Dependent upon the particle size of the inhaled medications, a large amount of the
particles can naturally deposit in both the oral pharynx and esophagus. With incorrect
inhaler technique, the amount of this deposition can increase. This increased deposition
is especially true in children due to smaller airways. As patients’ asthma control
decreases, prescription costs increase due to either added on oral medications or step up
therapy with inhaled medications (Price et al., 2012). Therefore, it is imperative to both
teach this population how to utilize an inhaler properly and to have return demonstration
from the patient (Pedersen et al., 2010).
Both pediatricians (MDs), as well as nurse practitioners and physician assistants
(NPs and PAs), provide pediatric based care to most children in the United States.
However, these providers are not always trained in correct inhaler technique or asthma
education. In multiple studies, healthcare providers neither teach inhaler technique to
patients nor know how to teach inhaler technique (Amirav, Goren, Kravitz, & Pawlowski,
1994; Duerden & Price, 2001; Jones, Holstege, Riekse, White, & Berquist, 1995; Sleath
et al., 2012 Reznik, Ylie-Rosett, 2014).
Since joining the clinic in August 2017, I have had several conversations with
both providers and nursing staff regarding current asthma care standards. Currently, the
nurses and providers teach patients and their families inhaler technique verbally,
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however, no hands-on demonstration or return method occurs. Consequently, the clinic
does not know if patients can properly perform proper inhaler technique. Therefore, the
question arises, in pediatric patients with asthma (P), how does the addition of hands-on
inhaler education (I) compared to only verbal inhaler education (C) affect inhaler
technique (O1), appropriate utilization of medications (O2), follow up clinic visits for
exacerbations (O3), ER utilization (O4), school attendance (O4), and parent work
attendance (O5) over a 3 month period of time?
Selection of EBP Model and Theoretical Model
Clinical scholar model. Evidenced-based practice melds research, clinical
practice, and patient preferences into one entity. The Clinical Scholar Model was
developed to initiate clinical questions, the spirit of inquiry and to initiate the education
of healthcare team members in the evidence-based practice process. A hallmark of the
Clinical Scholar Model is providing mentorship to others in evidenced-based practice
(Dang et al., 2015). The author of the model believed that point of care nurses could both
perform and utilize research at the patient care level. Therefore, nurses and other team
members became part of quality improvement at the unit level. Not only does the team
learn how research and evidence-based practice (EBP) evolve together, but also how to
utilize EBP in the healthcare setting. With EBP, healthcare teams can move practice
forwards, rather than remaining stagnant in “how care has always been performed.”
Sustainability of EBP is a hallmark of the model. EBP begins with a spirit of inquiry
then to critiquing and synthesizing the evidence and then placing the evidence into
clinical practice by applying the evidence into the care setting and evaluating generated
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outcomes (Dang et al., 2015). Dissemination of the outcomes to other healthcare
members and teams is an expected endpoint of the process.
The spirit of inquiry is the starting point of an EBP project. The clinical
significance of the problem (how to improve inhaler technique and asthma outcomes for
pediatric patients) is discovered and discussed. Then, the clinical scholar analyzes the
available evidence- both external and internal. The external evidence involves database
literature search and then a thorough critique and synthesis of the literature. Internal
evidence requires a comprehensive review of the clinic’s direct care daily processes:
chart reviews, quality, and risk analysis, as well as a review from provider/nursing as
well as patient/family perspectives of the clinical issue. A written proposal for action is
created, and if required, internal review board (IRB) permission obtained (Dang et al.,
2015). Adherence to the EBP process in a scholarly project is both ethically and morally
necessary. By adhering to EBP standards, the healthcare provider can make sure that
patients and families are not harmed by erroneous information, and justice for the patient
is realized.
The Clinical Scholar Model then requires a thorough review of the proposal in
action as well as outcomes from the EBP project. Quality measures allow for continuous
feedback regarding both outcomes and sustainability of the EBP project in the clinic.
EBP scholarly projects are only ethical to do it they are worth doing; in other words, the
previous critical appraisal piece is crucial. If the evidence supports a change in practice,
it would be ethically negligent to not implement an improved patient care process
(O’Mathuna, 2015). Dissemination of the project outcomes then occurs to contribute
towards improved nursing practice. Dissemination is also an ethical process. If the
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scholarly project has outcomes that will improve patients’ lives, then it is imperative to
disseminate the information. Likewise, if the project does not have similar outcomes as
noted in the evidence or any adverse effects upon patients, then the healthcare world must
also be notified of these occurrences (O’Mathuna, 2015). A schematic for the Clinical
Scholar EBP Model can be found in Figure AA4 in Appendix A.
Functional mastery of health ownership model. The Functional Mastery of
Health Ownership Model (FMHO) is a new model aiding the advanced practice nurse
(APRN) to empower the patient and family to own their health. FMHO consists of 4
foundational influences: 1- the patient perception of health, 2- self-efficacy, 3- social
resources, and 4- the personal perception of mastery (Donnelley, 2018). Wellness is not
merely the absence of disease, but also involves the holistic self: physical, psychological
and social wellness (WHO, 2017). The FMHO also allows for the patient and parents to
make decisions regarding their care and to gain the responsibility required to achieve
wellness (Donnelley, 2018). At each point in the model, supports are present to empower
the patient to learn how to care for their self. Thus, the concept of ownership is born. As
the patient and parents receive essential tools to aid him/her in health decision, he/she can
learn responsibility, mastery as well as obtain improved self-image and self-efficacy
skills; all of which are attributes of ownership of health (Nickels-Nelson, 2018). Selfefficacy is the crux of the model; with self-efficacy, the patient or parent has the
confidence to perform their health care and are physically able to carry the care plan out.
Quality of life measurement is also crucial. The model supports using quality of life
measures that document patient and family beliefs of their quality of life over the past
two weeks (Donnelley, 2018).
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Ultimately, the patient moves to the final stage of personal perception of masteryhow he or she views his or her ability to own one’s health. This pivotal point leads the
patient either to or away from a state of wellness. How the patient views themselves, as
well as his or her diagnosis and treatment, will either allow for ownership of disease and
ultimate wellness or hamper the progression towards wellness. This self-identity
contributes to the wholeness or holistic view the person holds of self (Karnilowicz,
2010).
FMHO starts by examining the patient’s perception of his or her health. These
perceptions, such as symptoms and quality of life measures, provides the foundation of
how the patient and family regarding disease and its treatment (Laforest et al., 2009).
The second foundational point in FMHO is self-efficacy. The patient and family will
learn responsibility as well as self-management skills to continue in a state of wellness
with their current diagnosis. Knowing that he or she can self-manage his or her disease
allows for self-efficacy to occur. Social resource utilization is the third step in the model.
Further education as well as having responsibility for his or her care becomes
emphasized. The patient and family learn what resources are available to them for selfmanaged care; transportation, social networks, and social programs are just a few
examples. Personal perception of mastery is the final checkpoint in the FMHO. The
patient and family duo have received all the tools necessary to empower ownership of
health and wellness. This empowerment leads to the expected belief that he or she will
continue to be successful with matters of healthcare. Persons who believe that they are
capable of being successful with their health will often have continued engagement with
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the medical team as well as seek further knowledge about their condition (Laforest et al.,
2009).
Empowering patients and families is an expected outcome of the FMHO. An
ethical imperative in this model is to empower the patient and to respect their wants and
needs. As healthcare providers, the end goal is to improve outcomes. “The principle of
empowerment is reinforced by that of social responsibility, and the principle of respect
should be seen as including respect for true personal autonomy where it does not involve
harm to others” (Tannahill, 2008, p. 387). Theory helps to guide healthcare interventions
and allows for proposed health outcomes to be realized. As Tannahill (2008) continues
to note, theory should cover the entire range of ethical principles in healthcare and not
just the concept of beneficence. Theory should help guide the evidenced-based process
in asking the clinical questions and critiquing the evidence to then put into practice.
Then, theory should help answer the question, what effects would an intervention as
proposed be likely to have on health (equity) and what reason do we have to believe that
it would help empower people?” (Tannahill, 2008, p. 388). Theory helps to guide the
clinician to examine potential harms in the proposed interventions and allows the
guidance to steer patients and families away from these harms (Tannahill, 2008). A
schematic of FHMO is found in Figure AA5 in Appendix A.
Systematic Search for Evidence Process and Results
CINAHL, PubMed, Psych Info, ScholarWorks, and Virginia Henderson databases
were utilized to conduct the systematic search of the literature. MeSh terms and search
terms comprised in the PICOT question included: pediatric, asthma, inhaler technique,
nebulizers and vaporizers, school abs*, and emergency room utilization. Limiting
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elements for the search included ages five to eighteen, peer-reviewed, and the English
language. A yield of 1,334 articles which met the above search criteria was retrieved.
Of the above 1,334 articles, 1,304 were excluded. The exclusions causations
included: 74 duplicate citations and 1,229 of the articles did not meet project needs and
outcome goals (inhaler technique, school, emergency room utilization and asthma
control) or the population (pediatric aged 5-18). Two articles were located through
references noted in the keeper studies. Figure 6 in Appendix A denotes the Literature
search process.
The hierarchy of evidence classifies each article into six categories; from the
highest levels of evidence to the lowest. These six categories are level I: systematic
reviews, level II: Randomized Controlled Trials; Level III: Controlled Cohort Studies;
Level IV: Uncontrolled Cohort Studies; Level V: Case studies, Qualitative and
Descriptive Studies, EBP Implementation and QI project; and Level VI: Expert Opinion.
Utilizing evidence which falls in the higher levels of evidence equates to using
knowledge which most likely will relate to current day practice and will allow for reliable
healthcare outcomes in practice (O’Mathuna & Fineout, 2015). Table AB2 in Appendix
B shows the hierarchy of evidence. Once the hierarchy of evidence is noted the critical
analysis can begin.
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Chapter 2: Critical Appraisal of Evidence; Model of EPB & EPIP Plan: Part 1
Rapid Critical Appraisal
There are four phases of critical appraisal once the beforementioned literature
search is completed. Critical appraisal is required to determine how worthy each study is
to the clinical question. Each article is assessed for the following: the level of evidence,
the study’s validity, the reliability of outcomes and any noted biases; and its applicability
to practice. The final step of Critical Appraisal is the evaluation and synthesis of the
evidence for the project (Fineout-Overholt, Melnyk, Stillwell, & Williamson, 2010).
Two forms facilitate rapid critical appraisal, the Generalized Appraisal Overview
(GAO) and the Rapid Critical Appraisal Checklist (RCAC). The GAO and RCAC
provide for a streamlined process to review each article for the purpose, data collection,
outcome measures, validity, the reliability of outcomes, and any noted bias. The RCAC
further analyzes how each study could be applied within a practice setting. After
completing the GAO and RCAC on each of the studies found in the systematic search, 31
keeper studies were identified. A keeper study is a well-performed study that can help
answer my clinical question (Fineout-Overholt et al., 2010; Fineout-Overholt, 2015).
Ethics of critical appraisal. The primary purpose of performing a critical
appraisal of the evidence in a scholarly project is to make sure the evidence being utilized
is valid, reliable, non-biased and applicable to the project at hand; to provide better
outcomes for patients. Above all, the number one requirement for healthcare providers is
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not to cause harm to a patient; emotionally, spiritually or physically. This concept
encompasses both beneficence and nonmaleficence with beneficence being the concept of
bringing goodness to a patient and nonmaleficence being not causing harm to a patient
(O’Mathuna, 2015). Thus, it is essential to review all evidence minding these two
concepts, mainly when working with pediatric and adolescent patients. These patients
are not at the age of majority so are not able to make full decisions by themselves. Their
parents and guardians put their trust in the healthcare provider. With the pediatric
population, not only is the provider caring for the child but also caring for the family unit.
The provider must consider the entire family’s beliefs and values, not just the patient’s.
The family expects that the healthcare provider will offer the best care for their child;
care that will not cause harm to them. The families trust that the healthcare provider will
give the child the “latest data and technology” that is available to produce the best
outcomes (Palmer, 2009).
Therefore, as a healthcare provider, it is mandatory that critical analysis of the
literature and evidence be carried out in the manner described in the previous section. As
O’Mathuna noted, if the EBP process is not entirely carried out in all steps, “poorly
designed research studies and EBP project will waste valuable resources. . . and may lead
to practice that is neither effective nor beneficent” (O’Mathuna, 2015, p 520). To not
partake in the full critical appraisal process would lead to non-ethical practice. To
include any research in an evidence-based scholarly project that was poorly performed,
filled with bias, or had content which could potentially harm a patient would also be
unethical practice (O’Mathuna, 2015). Tannahill (2008) also noted that randomized
controlled studies are not the only studies necessary for an evidenced-based scholarly
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project. The scholar must employ the studies that consisted of the best research process
implemented in the best manner for the situation. Other forms of research, controlled
studies, descriptive, quasi-experimental, may provide better information for different
situations (Tannahill, 2008). It is therefore imperative for the evidenced-based scholar to
perform a complete literature search and review of all the available evidence.
Evaluation
After critically appraising the evidence, I compiled evidence and synthesis tables
for this Scholarly Project. All 31 of the keeper studies (plus one DNP scholarly project
and one nursing master’s thesis) had an average study time of 3 months. Four of the
studies utilized interprofessional and intraprofessional providers during study
implementation. All the studies noted with both verbal and hands-on patient inhaler
education along with a hands-on display of inhaler technique, inhaler technique improved
as well as asthma control. The evidence did not show a robust decrease in school or work
absences or decreased emergency room visits. The evidence and synthesis tables for this
scholarly project are found in Appendix B.
Synthesis
Patient and provider metered dose inhaler technique. The mainstay of asthma
treatment includes the use of inhaled medications through MDIs. Inhaled medications
provide increased symptom control with a decrease in residual side effects. There are
eight steps required for correct inhaler use: 1- Remove the cap of the inhaler; 2- Shake
the inhaler and insert into spacer; 3- Exhale breath; 4- Place mouthpiece in mouth and
close lips around; 5- Press down on inhaler canister once; 6- Inhale slow and deeply and
hold breath for 10 seconds; 7- Breathe out gently; 8- wait 30 seconds before next
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dose/puff (Alexander et al., 2016; Bourne, 1996; Deerojanawong, Sakolnakorn, Prapphal,
Hanrutakorn & Sritippayawan, 2009; Gillette, Rockich-Winston, Kuhn, Flesher &
Shepherd, 2016; Morin, 2012).
Parents, as well as pediatric and adolescent patients, viewed their ability to use an
inhaler correctly higher than their actual skills (Alexander et al., 2016; Burkhart et al.,
2005; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2000). When patients were
asked how confident they were in utilizing an MDI, over 75% of the patients stated they
had complete confidence. However, both completely confident and not completely
confident MDI users missed the same amount of inhaler steps, 1.5-1.8 steps, out of 8
steps (Alexander et al., 2016; Gillette et al., 2016). Rates from 12-92% of patients
misusing their inhalers were recorded in the studies both in and out of the United States
(Alexander et al., 2016; Burkhart et al., 2005; Chen et al., 2002; Deerojanawong et al.,
2009; Duerden & Price, 2001; Foland et al., 2002; Gillette et al., 2016; Janssen et al.,
2003; Kamps et al., 2000; Levy et al., 2013; Minai, Martin, & Cohn, 2004; Manriquez et
al., 2015; Sleath et al., 2012; Walia et al., 2006; Zivkovic, Radic, Cerovic, &
Vukasinovic, 2008). The inhaler technique steps most often missed include removing the
cap from the inhaler, shaking the inhaler, exhaling prior to actuation of the device,
placing the inhaler in the mouth between the lips, inhaling and holding breath for 10
seconds, and waiting 30 seconds before next dose (Bourne, 1996; Burkhart et al., 2005;
Capanoglu et al., 2015; Carpenter et al., 2015; Chen et al., 2002; Deerojanawong et al.,
2009; Foland et al., 2002; Gillette et al., 2016; Kamps et al., 2000; Janssen et al., 2003;
Manriquez et al., 2015; Morin, 2012; Pedersen et al., 2010; Reznik et al., 2014; Sleath et
al., 2012; Turkeli, Yilmaz, & Yuksel, 2016; Walia et al., 2006).
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Healthcare providers also do not know how to properly use an inhaler (Duerden &
Price, 2001; Jones et al., 1995; Reznik et al., 2014; Sleath et al., 2012). The most
recently published national asthma guidelines (2007) also have recommendations for
providers to demonstrate correct MDI technique to asthmatic children at all clinic visits
(Expert Panel Report 3, 2007). Resident physicians with presumed knowledge of inhaler
technique performed 3.7 correct inhaler steps (Amirav et al., 1994). Only 15% of nurses
and 28% of physicians could accurately show a patient how to use the MDI device
(Duerden et al., 2001). A train the trainer approach has been recommended in the
literature. Various means of healthcare provider education has been suggested, including
one-one sessions, webinar, video, and classroom-based methods. Even a single one-onone inhaler technique session can improve a healthcare provider’s inhaler technique
knowledge (Price et al., 2012).
MDI technique education. Educational programs have been shown to improve
inhaler technique (Alexander et al., 2016; Amirav et al.; 1995; Bourne 1996; Burkhart et
al., 2005; Capanoglu et al., 2015; Deerojanawong et al., 2009; Expert Report Panel 3,
2007; Foland et al., 2002; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2000;
Levy et al., 2013; Minai et al., 2004; Morin, 2012; Sleath et al., 2012; Zivkovic et al.,
2008). Evidence has shown verbal training alone does not elicit the same outcomes as
verbal and hands-on MDI training with return demonstration. By utilizing verbal and
hands-on education with patient demonstration, improved inhaler technique occurs
(Alexander et al., 2016; Amriav et al., 1995; Bourne, 1996; Burkhart et al., 2005; Foland
et al., 2002; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2000; Levy et al.,
2013; Minai et al., 2005; Morin, 2012; Munzenberger et al., 2007; Pedersen et al., 2010;
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Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008). Pediatric inhaler technique
scores increased 1.1 to 3.9 steps patients after verbal and hands-on education with return
demonstration inhaler technique training (Carpenter et al., 2015, Carpenter et al., 2016,
Gillette et al., 2016; Morin, 2012; Turkeli et al., 2016). Over time, the correct inhaler
technique decreases due to lack of education and reinforcement of technique. With
correct inhaler technique at one visit, can eventually begin to have an incorrect technique
in the future; therefore, it is imperative to continue with technique training at each visit
(Manriquez et al., 2015; Pedersen et al., 2010). Capanoglu et al. (2007), Munzenberger
et al. (2007), and Kamps et al. (2000) noted patients retained the correct inhaler technique
after three hands-on and verbal inhaler technique educational sessions. In 2007, younger
and older children’s inhaler technique were evaluated 2-3 months after one intensive
inhaler education program. 60% of the children had decreased inhaler technique
measurements after those months (Jones et al., 1995). Therefore, the evidence states
inhaler technique training is to be performed at every patient encounter.
Only 60% of primary care pediatric providers performed any asthma medication
education during visits. Training regarding daily management, including an explanation
of asthma action plans, occurred only 20% of the time. The pediatric patients were only
addressed and asked about their thoughts regarding asthma diagnosis and treatment 6% of
the time (Sleath et al., 2012). Chen et al. (2002) noted families only sought asthma care
services in the event of an exacerbation. Otherwise, asthma care is not administered
routinely in the primary care office. The evidenced-based guidelines for asthma care
suggest asthma follow up in the office every six months (Expert Panel Report, 2007).
Without receiving routine asthmatic care, approximately 22% of patient in one study had
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4 or more asthma exacerbations, 40% of children missed school (Chen et al., 2002).
Barriers to provider MDI education include lack of time during appointments, patients
not bringing MDIs to appointments, sample MDIs not available in the clinic, providers
themselves not knowing inhaler technique or how to assess on the checklist, and
patient/family disinterest (Chen et al., 2002; Reznik et al., 2013).
Verbal and hands-on MDI education interventions were studied from a minimum
of one month to a maximum of three years. Most of these studies were conducted up to
three months. Only three studies continued evaluations after their trials. These studies
included Minai et al. (2004) (continuation of Foland et al. (2002) study); Walia et al.
(2006) (re-measurement in 3 months); and Levy et al. (2013) (3-year chart review).
Outcome measures utilized. Inhaler technique and asthma control outcome
measurement tools were also utilized in the evidence. These outcome measures included
the asthma control test (ACT) (Carpenter et al., 2015; Carpenter et al., 2016; Expert Panel
Review 3, 2007; Sleath et al., 2012): Quality of Life questionnaire (QOL) (Expert Panel
Review 3, 2007); spirometry (Expert Panel Review 3, 2007; Foland et al., 2002; Levy et
al., 2013; Minai et al., 2004; Zivkovic et al., 2008); Ashtma Action Plan (AAP);
(Carpenter et al., 2015; Carpenter et al., 2016; Expert Panel Review 3, 2007; Foland et
al., 2002; Minai et al., 2004; Rodriguez-Martinez et al., 2017); inhaler technique checklist
(Alexander et al., 2016; Burkhart et al., 2005; Carpenter et al. 2015; Carpenter et al.,
2016; DeGroot et al., 2015; Expert Panel 3, 2007; Foland et al., 2002; Janssen et al.,
2003; Kamps et al., 2002; Levy et al., 2013; Minai et al., 2004; Rodriguez-Martinez et
al., 2017; Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008).
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The ACT and QOL assessment are both validated patient completed
questionnaires for the pediatric and adolescent age group. The ACT was developed for
children as young as age 4. A score of less than 19 on the ACT indicates decreased
asthma control over the past month. The ACT is comprised of 4 sections: 1-child
response to questions regarding asthma control; 2-activity limitations; 3- nighttime
symptoms of asthma; and 4- parental perceptions of daytime and nighttime symptoms
(Deschildre et al., 2014). With improved inhaler technique, the ACT measurement
increased from 18.6 to 20.3 (Carpenter et al., 2016).
The pediatric QOL questionnaire contains 28 patient answered questions. These
questions measure the patient’s beliefs towards how asthma has affected their lives over
the past week. Questions include how “bothered” their lives are due to asthma as well as
how “often” asthma symptoms occur over the past week. The questionnaire further
measures how asthma has emotionally affected the children over the past week. The
QOL questionnaire was developed for specific age groups: 4-7 years; 8-11 years; and 1216 years (Everhart, Smyth, Santuzzi, & Fiese, 2010). The FMHO model is based upon
self-efficacy; and measurement of quality of life scores over a two-week time frame is
vital (Donnelley, 2018).
The inhaler use checklist allows for an objective evaluation measurement of
inhaler technique by any provider. This checklist is the only validated tool available for
these purposes (Boccuti, Celano, Geller, & Philips, 1996). The checklist is comprised of
8 scoring areas. All areas receive either a score of 0 or 1; with 0 being not performed
correctly and one being scored correctly (Boccuti et al., 1996). Spirometry also is an
objective measurement metric to measure asthma control. However, FEV1 measurement
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did not change with improved inhaler technique. The authors commented since the study
was only conducted for one-month FEV1 measurement could improve with a longer
intervention time (Minai et al., 2004).
Improved asthma outcomes. With improved inhaler technique, an improvement
in asthma knowledge, control, and self-efficacy occur (Alexander et al., 2016; Burkhart et
al., 2005; Carpenter et al., 2015; Carpenter et al., 2016; DeGroot et al., 2015; Foland et
al., 2002; Gillette et al., 2016; Janssen et al., 2003; Kamps et al., 2002; Levy et al., 2013;
Minai et al., 2004; Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008). Faulty
inhaler technique correlates with reduced asthma control. With education, improvement
in both inhaler technique and asthma control occur (Levy et al., 2013). Parental and
patient asthma knowledge increases as asthma control increases. Compliance with
asthma care and self-efficacy improve. Fear of asthma decreases, allowing the patient to
have improved quality of life (Carpenter et al., 2015; Zivkovic et al., 2008).
Improved asthma control also led to decreased missed school days, and parental
lost productivity days. Adolescents with controlled asthma reported less missed days of
school (3.5% controlled asthma vs. 34% uncontrolled asthma missing class) as well as
decreased tardiness from school or having to leave early due to asthma exacerbations
(1.8% controlled vs. 28% uncontrolled). School children also reported an increased
ability to concentrate in school with improved asthma control. Parents of children with
uncontrolled asthma reported increased work absences due to asthma exacerbations
(Gillette et al., 2016; Schmier et al., 2006).
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Recommendation
Through the review of the composed evidence and synthesis tables; improved
MDI technique is positively correlated to both verbal and hands-on education in the
healthcare office. As seen in the evidence, most patients and families deem their inhaler
technique is correct. However, upon MDI technique evaluation, only 25-58% of patients
had correct MDI technique. Since inhaled medications act upon the small pulmonary
airways in the lungs, correct inhaler technique is mandatory for effective asthma control
and exacerbation relief to occur. If the patient only receives verbal training, the
percentages of improved MDI technique are less than those patients who received both
verbal and hands-on inhaler technique training. Therefore, for correct MDI inhaler
technique, both verbal and hands-on training with re-demonstration is required at every
encounter. To ensure patient education is performed, it will be a requirement for the
practice to have an audit system in place to monitor IT teaching and recording.
Healthcare providers do not automatically know how to use an MDI correctly.
Providers must also receive inhaler teaching. In the evidence, providers were not able to
provide correct inhaler education to patients without first being taught themselves.
Guidelines recommend that all asthmatic patients received MDI technique education at
every asthma visit. As shown in the evidence, only 20% of providers and nurses perform
MDI technique education.
Improved asthma outcomes do not only involve correct MDI technique. Evidence
has shown with improved MDI technique there is a correlation between increased asthma
knowledge and asthma control. Evidence has also shown with improved asthma control
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and knowledge; medication compliance increases as well. Patients can have a decreased
fear of asthma and have an increase in self-efficacy.
The cycle of emergent asthma care must be broken to improve asthma outcomes.
Any acute care asthma visit (office or ER) is equivalent to treatment failure. This failure
is accountable to not following self-management care; such as non-adherence to daily
medications as well as not adhering to treatment schedules such as having (or not having)
a written asthma plan and maintaining regular asthma chronic care visits in the office.
After these acute visits, patients and families often discontinue chronic medications or do
not fill ordered prescriptions. As well, primary care chronic management continues to
not take place (Ducharme et al., 2010). Therefore, primary care offices must help
patients and families take ownership of their chronic asthmatic care.
Objective validated outcome metrics are available and have been utilized to aid
with MDI technique measurement. The inhaler use checklist allows for all providers to
have one validated metric to streamline the evaluation process and allow for similarity in
the testing of MDI technique. The ACT and pediatric QOL, enable the patients to be
evaluated with the same measure of metrics. Patient and family can be part of the
asthmatic care plan. The AAP provides for the patient and family to have a roadmap of
asthma management at home.
Improved MDI technique in the pediatric and adolescent patients require new
processes for education and must be put into practice. All healthcare providers in the
office will first have their own MDI technique evaluated followed by verbal and handson training for any steps that were incorrect. The providers must be given educational
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sessions regarding how to evaluate and educate patients and families on how to correctly
use an MDI.
At every office visit encounter, asthmatic patients must have their MDI technique
evaluated and receive verbal and hands-on education. Asthma control is to be evaluated
to aid the patient and family. Inhaler technique must be evaluated using the inhaler
technique checklist and ongoing asthma control measured by the ACT and QOL scales.
The AAP must be updated at least every six months and as needed to allow for
individualized care planning to reduce asthma exacerbations.
EPIP operationalized through EBP Model and Theoretical Model
The Clinical Scholar Model was chosen for this Scholarly Project since the clinic
staff had never had an EBP project initiated in the office. I had to both teach all staff and
providers the EBP methods as well as mentor the staff throughout the project. This
model allows the team to view the forward movement required in each step of the
evidence-based process. As well, since the staff was new to both the EBP method as well
as an EBP project, mentorship would be required. Thus, the Clinical Scholar Model was
chosen. A schematic for the model in practice is noted in Figure AA7 of Appendix A.
“The FMHO allows for seamless care with the [child] who has asthma. The
wellness aspect of the FMHO is vital in that it allows the [child and family] to
function in a world of wellness rather than a world of illness with asthma. By
focusing upon ownership of health rather than a state of illness, the [child and
family] learn how to gain responsibility for their care. The family learns how to
own their asthma, meaning, they learn how to utilize the tools given to them by
the health care team to appropriately care for their asthma symptoms. The [child
and family] learn how to be responsible for asthmatic care, by taking prescribed
medications, learning their asthma triggers, and utilizing the beforementioned
tools. Mastery of their illness is obtained, and the [child] and family have the
keys to own their health and live in a state of wellness” (Nickels-Nelson, 2018).
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Figure AA8 in Appendix A is the schematic for the operationalized FMHO
theory in this project.
Fully Operationalized Project Plan/Logic Model
A logic model was essential to planning and implementation of this Scholarly
Project. Logic models are project planning tools that define the assumptions, inputs,
outputs, and outcomes of a project. The logic model allows one to examine what
thoughts led to the program design and desired outcomes. Assumptions allow for the
initial thoughts of what will occur throughout the implementation process. Key inputs,
such as resources of time, people, finances, and supplies are also planned into the project.
Barriers and facilitators can also be quickly noted. If the barriers appear to be too
powerful to overcome, the new plans can be placed into motion so full implementation
will not become a failure. Planned outcomes from short term to long term is noted as
well. Outcomes, then, are the endpoint of the logic model. A figure of the logic model is
found in Figure AA9 in Appendix A.
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Table 2A: Operationalized P0lan of DNP Scholarly Project
Assumptions for DNP Scholarly Project
Staff will learn how to utilize, teach
and train inhaler technique
Decreased utilization of healthcare
resources due to decreased asthma
exacerbations
Improved quality of life

Patients will learn inhaler technique
Decreased school absenteeism

Patients will have improved asthma
control
Resources & Inputs

•
•
•
•
•
•

People:
CHP-BPA nursing
CHP-BPA medical assistants
CHP-BPA providers
BMC respiratory therapist
Patients
Families

•
•

Organizational Support:
Financial Funding Request
Organizational support from
CHP senior management

Activities
Patients will receive the following care at asthma visits:
• Written, verbal & hands-on inhaler training from nursing
• Validated tool assessments of asthma control and quality of life
Outputs and Outcomes: With the above activities the patient will have:
• Improved inhaler technique
• Improved quality of life
• Decreased school absenteeism
Impact
• Improved state of health and ownership of health
• Decreased health care costs
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Chapter 3: Project Design and Methodology
Project Design and Methodology Overview
Setting/description of clinic. Pediatrician Dr. Thomas Whitfield started
Children’s Health Program in 1975 to provide both pediatric office and mobile care. He
noted several children presenting for kindergarten physicals yet had never been seen
otherwise since early infanthood. These children not only were lacking immunizations
but also social skills. Several children had unrecognized illnesses and developmental
delays. After 25 years of pediatric services, Children’s Health Program applied for
designation to become a federally qualified health center (FQHC) due to Berkshire
County’s need for improved health care in the adult community. Community Health
Programs (CHP) was born. The stated mission of the CHP is to, “measurably improve
the health of Berkshire County, Massachusetts” with a vision that “Berkshire County’s
population will be the healthiest in Massachusetts” (Community Health Program, 2017).
In 2018, the FQHC now operated as one practice with ten locations; including
internal and family medicine, obstetrical/gynecology care, pediatric medicine, and dental
care. After a recent Uniform Data System (UDS) review, 1 out of every 5 Berkshire
County persons receives care at the FQHC.
Project design and methodology overview. As was discussed in Chapter 2, this
DNP scholarly project was fully developed upon the evidence-based process. A full
review of the literature along with a synthesis of the evidence allowed for the creation of
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this asthma project. All clinical members of CHP-BPA were involved in the project.
These members included the medical assistants, nurses (both licensed practical nurses
(LPN) and registered nurses (RN), and providers (nurse practitioners and physicians).
The project director (PD) was Gina Nickels-Nelson.
The methodology for this project included hands-on along with verbal inhaler
technique training at every asthmatic patient visit to the office. Inhaler technique scores
were obtained before any education being given and then recorded again post education.
At each care visit, the patient and family also completed the asthma control test and
quality of life questionnaires. Each patient also was to receive a completed asthma action
plan at each visit. The implementation time for this project was three months, JulyOctober of 2018.
Fully Operationalized Project
The inhaler technique education project was conducted at CHP-BPA from July
through October 2018. The project included both a pre-implementation phase and an
implementation phase.
Pre-implementation phase. During the pre-implementation phase, the staff at
CHP-BPA received education regarding EBP. As well, the project outline, expectations,
and outcomes were discussed at length. Since the basis of the project was inhaler
technique, the expertise of a respiratory therapist was sought. The head of the RT
department at BMC was contacted, and I met with her along with our head nurse to
discuss how to both use and teach inhaler technique. This expertise was then brought
back to the office, and all nursing staff had their inhaler technique evaluated. The
nursing staff learned how to teach and evaluate inhaler technique.
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As well, during the pre-implementation phase of the project, all tools were
acquired for project implementation and completion. These tools included:
•

Inhaler technique checklist

•

Emergency room/urgent care utilization questionnaire

•

Patient/Family reported school/work absenteeism questionnaire

•

Asthma Control Test (ACT)

•

Pediatric/Caregiver Quality of Life Questionnaire (QOL)

•

Asthma Action Plan (AAP)

CHP also developed an introductory letter describing the new asthma program to
families. A take-home inhaler technique letter was also acquired from an online
source that allowed for copying to occur.
Implementation phase. All clinical staff of CHP-BPA was active within the
project during the time of implementation. At the onset of each day, the medical assistant
was to evaluate their provider’s schedule and locate any patient aged five and older with
an active diagnosis of asthma. These patients were also to have had an MDI ordered as
well. Once located, the asthma packet (as described above) was given to the patient to be
completed. While the provider was with the patient, asthma control was to be assessed
with the ACT and QOL forms; along with exam completion. The provider would then
complete the AAP. The AAP is a written plan of care outlining asthma self-care
measures and step-up treatments required for worsening symptoms. The form is depicted
as a traffic stop light: Green: no symptoms (daily actions needed); Yellow: start of
symptoms or cold/allergy symptoms (daily actions plus new controller or rescue
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medications and call to provider office); and Red: emergency care needed (daily actions
plus emergency actions and immediate patient care required) (Booth, 2012).
Finally, the patient’s inhaler technique was evaluated. With the use of a placebo
inhaler and spacer in the office, the patient demonstrated their technique. The total
number of correct technique steps was noted on the inhaler technique checklist. Then,
the patient was given both verbal and hands-on education. After this education, the
patient again demonstrated their technique. The total number of scores was noted again
on the inhaler technique checklist.
The full implementation process and progress markers are found in tables AC1-2
in Appendix C.
Process indicators with lessons learned, barriers and solutions
Stakeholders. Determining stakeholders in any implementation project is key to
project success. Stakeholders can hold active as well as passive rolls and can be both
facilitators as well as barriers to the implementation process. All patients aged five and
older with asthma had the opportunity to participate in this scholarly project. If the
patient was only on nebulized medications, then they were excluded since a nebulizer is a
different form of medication delivery.
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Table 3A: Stakeholder Analysis
ACTIVE STAKEHOLDERS
Pediatricians (6)
Nurse Practitioners (3)
Physician Assistant (1)
Registered Nurses (5)
LPN (1)
Medical Assistants (8)
Front Desk (8)
Senior management CHP (5)
Dr. Lamm, CMO (1)
Practice Administrator CHP BPA (1)
Patients and Families

PASSIVE STAKEHOLDERS
Back office staff (3)
Billing (1)
Senior Management CHP (5)
Senior management CHP (5)
Practice Administrator CHP BPA (1)

Data collection. Data collection, record keeping, and management were also
essential components of the implementation plan and had to be planned before the project
began. With the recent merger to CHP, CHP-BPA had started to use a new electronic
medical record (EMR). Unfortunately, the EMR was not capable of reporting vital
information for many quality measures. Thus, most of the data keeping was required to
be kept in a binder as well as monitored through a quality improvement database,
Azarahealthcare.
Data collection during the implementation period was vital for both patient
privacy as well as implementation success. Each paper record was sent back to PD desk
for evaluation. Patients received a patient number that was devoid of any identifying
data, such as name or social security number. A master list linking the patient number
and identifying patient information was kept in a locked drawer in the PD office. In this
manner, the evaluation of the implementation process was continued without sacrificing
any HIPPA or privacy matters. The Excel file was kept on PD’s personal computer
devoid of any identifying information as mentioned above. This personal computer
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requires three personal identification markers to log in. After all, forms were inputted
into Excel; the forms were placed into HIPPA bins and taken for shredding per CHP
policy.
Table 3B: Documentation Metrics for DNP Scholarly Project
Metric
How
Document/Records
Kept per
Implementation
Protocol
• Pre• Inhaler use
Implementation
checklist form
with
provider/nurse
• Nursing and
number was
Provider MDI
placed in binder
technique
on bookshelf
behind PD’s
desk
• Metrics were
placed into Word
Excel file under
preimplementation
• Excel was
utilized for ease
of metric
analysis
• Initial Visit and
• Meditech used
Subsequent Visits
to review visits/
Must have
account and log
• IT assessment
in from BMC to
utilize
• Emergency
Room/Urgent Care
• Once logged
utilization (on IT
into Meditech
checklist)
searched by
patient name for
• Asthma Control
ER utilization
Test (ACT)
•

Pediatric/Caregiver
Asthma Quality of

•

Initial visit
patient packet
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Metric

Life Questionnaire
(QOL)
•

Asthma Action
Plan (AAP)
completion

•

Missed
School/Parental
Work Day
questionnaire (on
IT checklist)

How
Document/Records
Kept per
Implementation
Protocol
sheet placed in
a binder on the
bookshelf
behind PD’s
desk. Was not
faxed to EMR
since not official
part of patient
record
•
•
•

Initial patient
packet found in
Appendices
Metric inputted
into Word Excel
file for initial visit
Excel file used
for ease of
metric analysis

Budgetary planning. Since the office was utilizing all the current staff for this

project, new staff acquisition was not a requirement. As well, the clinic did not need to
acquire any new office equipment. The office already had computers, copy, fax, and
label maker machines. All providers had their stethoscopes and watches for assessments.
New costs that were needed to be considered for this project included the time for
nursing staff in performing MDI technique education as well as this writer’s time in
implementing the project as well as metric evaluation. All employees of the office were
already receiving their respective salaries. There were not any new monies released for
salary with this proposal; however, hours spent on each employee on the project were
tabulated. These costs included medical assistant, nursing and provider care and time

33

with patients and families. Dr. Lamm graciously extended 500 dollars towards the
purchase of aerochambers for this project.
The MAs also had a planned 30-minute meeting with PD discussing their
requirements for the asthma EPIP project. MA time with patients was consistent with the
delivering of asthma patient forms to both patients and PD. A medical assistant’s salary
is $15 per hour and the expected time per patient was 5 minutes.
Nursing (licensed practical nurse (LPN) and registered nurse (RN)) also had
meetings with PD to discuss their role in the Asthma project. The evidenced-based
process was also discussed. Nursing also had a 30-minute session with PD measuring
their inhaler technique and how to teach inhaler technique to patients and score the
inhaler use checklist. Each month, nursing and PD met to discuss the project and
brainstorm any changes that were required. Nursing spent on average ten minutes with
each patient during an asthma visit to teach, measure and record patients inhaler use.
Nursing salary is $30 per hour.
Nurse Practitioners, Physician Assistant, and Physicians (MD/DOs) also had an
initial meeting with PD to discuss the project and their roles for the Asthma project. The
evidenced-based process was also discussed to differentiate the EBP process from
research. The providers also had a planned 30-minute session with PD measuring their
inhaler technique and how to teach inhaler technique to patients and score the inhaler use
checklist; however, none of the providers except PD performed this task. Therefore, this
amount was not recorded in the budget. Review of the ACT, QOL, and AAP was to be
discussed. Each month the providers and PD were to have a 30-minute meeting to
discuss the project and brainstorm any changes that were to be required. The providers
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stated that time was a barrier for these meetings, so very brief 5-10-minute status update
meetings occurred. Providers had visits in length from 20-40 minutes depending on visit
type (sick visit, prolonged sick visit or well care) in which asthma control was
established, treatment plans were discussed with families, and the use of inhalers was
encouraged. PDs time for all data collection and analysis was also tallied; however, not
paid out for this project. Average Nurse Practitioner salary is $43 per hour, and the
average MD salary is $85 per hour.
Office supplies, such as paper, needed to be factored into the budget. These paper
supplies were vital since the EMR did not allow for the retrieval of metrics.
A projected budget expense of $16,156 was projected. Once the full project was
completed the real budget was decreased. The actual budget spent on this project was
$10.065.58. Below is a table of the budget.
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Table 3C: Actualized Budget for DNP Scholarly Project
Role/Salary
Duty
Number of
Contact
Hours
Medical
review patient for
10 minutes
Assistant:
protocol; give
x 119
$15/hour
screening forms
patients
Medical
Training time with PD 30 minutes
Assistant
for project
$15/hour
RN/LPN:
Training of nursing
30 minutes
$30/hour
inhaler technique
per
RN/LPN
RN/LPN:
Patient inhaler
60 minutes
$30/hour
technique
per
education/review for
RN/LPN
protocol
RN/LPN:
Monthly progress
60 minutes
$30/hour
meetings with PD
per
RN/LPN
RN/LPN:
Education/assessment 10 minutes
$30/hour
IT with patients
per
(assumption of 200
RN/LPN
patients with 2 visits
each)
NP $43/hour
Project protocol
60 minutes
training
per NP (2
NPs)
NP $43/hour
Monthly progress
60 minutes
meetings with PD
per NP (2
NPs)
NP $43/hour
Provider time with
30 minutes
asthma patient
with NP
MD $85/hour
Training with
30 minutes
respiratory therpaist
with MD
(5MDs)
MD $85/hour
Training time with PD 60 minutes
project
per MD (x
5)
MD $85/hour
Monthly protocol
60 minutes
meeting
per MD (x
5)
MD $85/hour
Provider time with
30 minutes
patient
with MD
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Total cost

$297.50

$60.00

$90.00

$90.00

$240.00

$595.00

$21.50

$86.00

$1025.00
$0

$148.75

$446.25

$1005.80

Role/Salary

Nursing time
with patient
(nurse visits)
GMN project
time
Total Salary:
Office Supply
Copy paper and
ink toner
1309 pages

Missed
opportunities
copies
Pens
Aerochambers

Duty

Nurse visits (vaccines,
suture removal, etc)
Project overview, data
entry, analysis

Number of
Contact
Hours
20 minute
patient visit
24 weeks

Total cost

$140.00

$5,160.00
$9,405.80

Reason

Cost

Copying of
assessment forms,
verification forms,
asthma education
forms

$78.55

76.25

Filling out packet
forms (patients)
2 for placebo inhalers;
remainder for patients
not able to pay copay
for spacer

$5.00
$500.00

Total

$659.78

Grand Total

$10,065.60

Revenue generation. Patient billing revenue was performed for every aspect of
the asthma inhaler technique program. Billing was generated immediately with each
patient encounter. Since CHP-BPA is a federally qualified health center, all providers
(both MD and NP) can bill at 100%. The three main commercial health insurance
companies seen at CHP-BPA were Blue Cross Massachusetts, Health New England, and
Aetna.
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On March 1, 2018, Massachusetts Medicaid formed Accountable Care
Organizations (ACO) in Massachusetts. These ACOs are arranged by county. Each
provider office in Massachusetts was given a choice to either join the ACO or not. By
joining the ACO, the payment structure changed from one of volume payment (payment
per patient) to one of performance payment (payment for performance). Thus, each
enrollee’s visit is reimbursed at the same amount, regardless of medical complexity. At
the end of each year performance markers, such as asthma care outcomes, are monitored
and evaluated. Incentives are then given to high performing offices.
Budget justification. With the intended project outcomes, children would have
fewer asthma exacerbations. With fewer exacerbations, the clinic would be able to see
other patients for urgent visits. Thus, further revenue would be generated, and decreased
use of urgent care and emergency room facilities may be realized. With Berkshire county
not having a pediatric tertiary hospital with PICU services, costs savings would also be
evident through fever ground/air ambulance transports. In the office, with this project,
CHP-BPA would be able to justifiably bill at least a 99214 or 99215 based on asthma
severity scoring, quality of life monitoring, inhaler technique teaching and patient visit.
With the commercial insurers upcoding could realize:
•

From a 99213 to a 99214: increased reimbursement $37

•

From a 99214 to a 99215: increased reimbursement of $45

•

From a 99213 to a 99215: increased reimbursement of $81
This return on investment (ROI) in asthma education could actualize a 5-14-dollar

ROI per asthma education dollar spent (Berkshire Health Systems, 2015). At the onset of
the project, I sent each provider and nurse billing data that could be billed since enhanced
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asthma teaching was being documented during visits. These codes included MDI
technique teaching (94664) as well as codes for patient questionnaires (ACT and QOL)
(96160).
An audit of billing was performed of the 119 project patients. All the providers
participating in the program submitted superbills after each patient visit. These 119
patients had a combined total of $16,034 gross billable income. Several missed
opportunities in billing were realized, including not capturing the modifier 25 coding
with a well visit for asthma education as well as inhaler technique education coding. A
gross total of $19,983 could have been realized if these two billing measures were
captured. Finally, these 119 patients had a collective amount of other missed billing
opportunities; they were seen for subsequent visits but did not have any asthma teaching
or evaluation performed. If they had received this evaluation, then another $3,074 could
have been realized in gross billing. A total of $7,023 missed revenue was realized.
Separate from billable income, as CHP-BPA implements improved asthma care
with metrics in daily practice, reportable measures will now be captured within Athena
EMR as well as Azarahealthcare. CHP can then report these measured metrics to
national quality programs, such as UDS and HRSA. With these reportable metrics and an
assumed improvement in asthma care and outcomes within the practice, CHP-BPA will
collect increased revenue with quality measures. As stated earlier, the ACO payment
structure is now one of performance rather than volume-based payment. Thus, with
decreased ER utilization, hospitalization, improved medication compliance, and asthma
severity, incentive payments would be available to CHP-BPA. Since the ACO has just
initiated in early 2018, these incentive payment structures are not yet available.
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Lessons learned and barriers. At the onset of the proposed program at CHPBPA, I had obtained buy-in from all clinical personnel at the office, except our lead
physician. As I look back upon the pre-implementation phase of this project, I spent too
much time with our lead physician; attempting to win his favor for the project. Instead, I
should have focused more efforts upon the rest of the staff. Ultimately, when it came
time to implement; the entire team stated an initial refusal to move forward. Even though
all portions of the project had been discussed with each level of provider; all noted no
recollection of having a role to play in the project. I, therefore spent an extra week
speaking with each member of the team individually. After having discussions with
individuals, the nursing staff became champions for this program. A few of the MAs
voluntarily participated in the program, but for most of the program I needed to give daily
reminders to the staff.
Change was another barrier to this project. Before my arrival at the clinic last
year; 3 MDs and 1 NP had retired. The clinic, also facing financial difficulties, decided
to merge with CHP. This merger itself caused change. I also created change when I
arrived at the clinic; just by being a new provider to the practice. As well, I arrived as a
CHP NP, rather than a BPA NP. This, along with my collaboration with the CMO as my
industry mentor, has created an “us vs. them” work environment at times.
The medical assistants and nurses also determine the flow of the days and what
actions would and would not occur with the patient population. On more than one
occasion, one of the nurses interrupted a patient visit to tell me the nurses would not be
performing any asthma care that day. The MAs also carry this same power. Many of the
MAs would not locate their provider’s asthma patients for the day or initiate any asthma

40

packets for the program. By not locating their patients, I was then required to spend my
own time searching for upcoming asthmatic visits and preparing packets. Since patients
are scheduled as same-day visit, many of these patients were missed.
The day before the start of my implementation; our practice manager announced
her resignation. This resignation also created continued change in the clinic. After her
departure was announced, the clinic had resignations of three front and back office
personnel (medical records, billing, and reception) as well as one LPN.
With our change to CHP, all patients are required to fill out both a two-page
health history form as well as a ten-page patient registration form. This form is only
needed to be filled out once; however, we are still having patients arriving for care who
have not been seen for over a year or who are new patients to the practice. As well, at
every annual physical, each child and teen must fill out a developmental or depression
screening tool. Before the asthma program, families were already upset with the amount
of paperwork. With the asthma program, patients were now given an additional six pages
of forms to fill out. Some families expressed extreme displeasure. One father accused
me of “killing a forest.” I had one occasion where I walked into an exam room as an MA
was telling the mother, “yeah, it is ridiculous how much she is expecting you to do for
this.”
Our current EMR is not adequate to perform EBP care for our patients. At no
time has a reporting module been present to allow for the chart review process to occur. I
am not able to obtain a list of patients fitting the demographic criteria for this project. All
data had to be searched for retrospectively, and hand entered into excel. This process
was very long and tedious. With the EMR not being able to perform a simple search,
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each day I must hand search for asthmatic patients fitting the criteria for the project. The
expectation at the onset of the project was for MAs and nurses to also watch the
schedules and locate any newly added patients to the daily schedules fitting the criteria.
However, this did not occur during the project. Thus, a great many of missed
opportunities occurred. If the EMR had best care practices (i.e., IT protocol, ACT, AAP
locaters) then possibly the staff may have noted these patients required the IT program.
The current EMR does currently have a quality measure area and asthma control, and
AAP is drop downs on this list. However, this feature is not routinely utilized in the
clinic.
I had also planned on utilizing the Azarahealthcare database to help with patient
location as well as asthma measures. However, this database is only useful if the patient
already has a diagnosis of asthma listed in their problem list. The clinic had transitioned
from one EMR system to another in 2017. Patient charts are still not fully loaded with
past or current histories. Therefore, the database did not prove to be useful. As well,
several patients either had a resolved history of asthma (but the diagnosis was still present
on their dashboard) or never had the diagnosis placed as active.
The final barrier to this project was time. In our current scheduling system, all
MDs and one NP (myself) have 20 minutes to conduct a well-child physical; 30 minutes
for a teenage physical. The other NPs and PA have 30-40 minutes per well exam and 2030 minutes for sick care. This allotted time does not allow for in-depth discussion of
asthma; or for any other physical, mental or social care needs. Therefore, most of the
providers declined to participate fully in the program. None of the physician providers
would let the quality of life questionnaires be utilized for their patients. Reasonings
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included: “not supported by the AAP” (American Academy of Pediatrics);” too much
patient paperwork” as well as “time.”
The success of the program was the realization that our patient population does
not know how to use an inhaler. This success equates to this; we have much to do in the
realm of education and care of our patients at CHP-BPA. Now we have a roadmap to
follow to lead to this success. Another success occurred after implementation had
finished. Clinic staff were apprised of the results from this program. The providers are
now willing to move forward with an asthma medical home. Two MAs routinely come
to me now for the asthma packet when I have an asthmatic patient in the office. Our
patients also were provided spacers during the program. Many patients had never had a
spacer; or where not able to have two spacers (one for home and one for school). Upon
learning how to use their inhaler, they learned of the importance for the spacers.
Solutions. Before initiating any new programs at CHP-BPA, I now know that I
need to include the buy-in of every person in the clinic, and not to only focus on the lead
physician. I have learned of the power that is held by both the MAs and the nurses; thus,
I need to have their input and buy-in before moving forward with any new initiative.
This past fall, CHP-BPA acquired a new practice manager. He had already been a
practice manager at a sister site within CHP. Thus, he is knowledgeable of both business
and personnel flows within the agency. He is also very interested in hearing about this
new asthma program and how the program can both positively affect our patients as well
as the office financially.
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All of CHP is transitioning to another EMR in July 2019. Even though this will
be yet another change, I do feel that this EMR will be far superior to our current program.
The new EMR will have built-in reporting capabilities. Best practices are also a part of
the program. I am hopeful that the superior EMR will be a benefit to our asthmatic
patients shortly. We also will not need to rely upon the Azarahealthcare database once
this EMR is in place.
Finally, one of the most significant barriers to this project was time itself. After
reviewing the outcomes of the project with the providers, all the providers are on board
for improving asthmatic health care in our office. We are moving forward to expand care
in an asthma medical home environment. Thus, we will have dedicated time every
quarter to meet with our asthmatic patients.
Evaluation of EBP model, theoretical model and logic model function within EPIP
All three models (Clinical Scholar EBP, Functional Mastery of Health Ownership
and the Logic Model) were instrumental in the development, implementation, and
evaluation of this DNP Scholarly Project.
The Clinical Scholar model allowed for the seamless implementation of the
evidence-based process to become embedded in this project. The reason for this choice
was the mentorship piece of the model. Before this project, CHP-BPA had not had an
EBP quality improvement project take place. While the providers were knowledgeable
of EBP, the medical assistants and nurses were not. Through mentorship, the staff
learned of the importance of EBP and how to effectively implement into practice.
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The Functional Mastery of Health Ownership (FMHO) theory also guided this
project. Our patients not only learned how to use their inhaler correctly but learned of
tools to keep their asthma in control. By giving our patients and families these necessary
tools, they learn self-efficacious behaviors that will hopefully lead to asthma control
improvement. I did find one new approach to care which will need to be a future
consideration to this model. We as health care providers cannot expect our patient to
learn how to own their health unless we as providers learn how to own the care that we
give to our patients.
The logic model was instrumental in the pre-implementation process. I did find
that it helped me to think of potential barriers, facilitators, and resources that would be
required for this project. However, I did not find it to be as useful once the
implementation started. Several barriers presented themselves, and I did not expect these
to occur. I could envision the logic model being re-formatted monthly for future projects
to more smoothly guide the implementation process.
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Chapter 4: Project Outcomes, Impact, and Results
Over the past three chapters of this DNP Scholarly Project, I have followed the
EBP process as it relates to my clinical problem of decreased knowledge of inhaler
technique and asthma control. I reviewed the available evidence to develop a best
practice protocol to put into place at CHP-BPA. Then, per the Clinical Scholar EBP
Model, I mentored my team in the EBP process. The Breathe In Breathe Out Inhaler
Technique Education Program was put into practice at CHP-BPA. Now, it is time to
evaluate the outcomes. Evaluating outcomes in an EBP best practice pilot project is
essential. The effectiveness of the plan needs to be assessed and then later disseminated
to assure that patients continue to receive the best care that is evidence-based (Brewer &
Wojner Alexandrov, 2015).
Completion Outcomes, Data Collection, Measurement
Demographics. From July 5 through October 19, 2018, 312 asthmatic patients
utilizing an MDI between the ages of 5 and 20 received care at CHP-BPA. These
patients had a combined total of 518 distinct patient encounters. The age ranged from 5
through 20 with a mean of 11 years. One hundred thirty-six males, 175 females, and one
transgender patient were seen during the project. Seventeen insurance payers covered
these patients; with Fallon Health ACO covering most of the patients followed by Blue
Cross Blue Shield (BCBS) of Massachusetts. The primary residence of most of the
patients was Pittsfield; however, the entire Berkshire County had representation along
with five towns in Eastern New York State.
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Visit types and inhaler technique program. Most encounter type visits were
for sick care (187) followed by well care encounters (144). Ninety-three of the visits
were solely nursing visits (suture removal, immunizations, etc.). Sixty-nine asthmatic
specific visits (exacerbations as well as follow up care) were performed.
Ten pediatric providers along with nursing staff provided care during the inhaler
technique program. Of these providers, one physician declined to perform the program.
The remainder of the providers and nursing staff participated in the program. One
hundred nineteen patient visits received the inhaler technique asthma program. Three
hundred ninety-nine missed opportunities otherwise occurred. The reasons for the missed
opportunities included “no time,” missed chance, MA or nursing forgot; provider not yet
in implementation; computer technical error; provider declining to participate, and patient
unwillingness. 25% of the patients received the inhaler technique program of care, and
75% of patients did not.
Provider inhaler technique scores. At the onset of this program, the intent was
to measure all providers as well as nursing staff with their inhaler technique knowledge.
However, all pediatric providers stated they did not have time to teach their patients
inhaler technique, thus did not wish to display their inhaler technique. The nurses were
all evaluated for inhaler technique before the program. All nurses were able to perform
the eight steps correctly before the program.
Inhaler technique checklist demonstration scores. Inhaler technique (IT)
demonstration scores ranged from 0, meaning 0 correct IT steps, to 8, indicating eight
correct IT steps out of 8 steps. One hundred nineteen patients participated in IT
education. Inhaler technique was assessed by either nursing or Gina Nickels-Nelson
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(PD) before any training. Then, the patient received both hands on and verbal inhaler
technique education; per the developed protocol that was based upon best practice from
the reviewed evidence. The patient’s inhaler technique score was then reassessed. As
was seen in the previously reviewed studies, patients improved their inhaler technique by
at least one step after receiving both hands on and verbal inhaler technique education.
Table 4A: Inhaler Technique Checklist Demonstration Scores
Inhaler Technique
Number of Steps
Checklist Demonstration
Correct Before
Score
Education
0
3

Number of Steps
Correct After
Education
0

1

1

0

2

1

0

3

1

0

4

7

0

5

17

0

6

30

0

7

34

3

8

25

116

Thirteen patients were seen on a subsequent visit within the project 3-month
timeframe. Each of these patients had a perfect score of 8 at their first visit; however, at
subsequent visits, their score decreased to 5 correct steps. These results indicate that
inhaler technique must be reviewed and assessed at multiple visits; not just one time per
year. The same trends of decreasing inhaler technique were also noted in the reviewed
studies.
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Asthma control test (ACT). Of the 119 patients who participated in the project,
93 filled out an ACT questionnaire. ACT scoring ranges from 0-27; with 0-18
demonstrating poor asthma control and 19-27 demonstrating good asthma control. The
range of ACT scores were 3 to 27. The mean ACT score at the first visit was 21. At a
second office visit, 17 patients completed an ACT, with a mean score of 17.
Table 4B: ACT Scores at Visit 1 and Subsequent Visits
ACT Score
Number of Patients,
Visit 1

Number of Patients,
Visit 2

3

1

7

1

1

10

1

1

14

2

15

3

16

2

17

4

18

12

19

9

20

11

21

11

4

22

15

2

23

9

24

10

25

20
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2

2

2

26

2

27

7

Mini pediatric and caregiver asthma quality of life questionnaires (QOL). A
total of 75 patients and 76 caregivers completed the asthma QOL questionnaires at the
onset of the office visit. Four out of ten providers declined to utilize this questionnaire.
The pediatric questionnaire has three sections: asthma symptoms; emotional symptoms;
and activity limitations. All scoring is completed by a Likert scoring system as follows,
with lower scores being representative of increased concerns:
•

“How bothered have you been during the last week” with symptoms
o 1: extremely bothered
o 2: very bothered
o 3: quite bothered
o 4: somewhat bothered
o 5: bothered a bit
o 6: hardly bothered at all
o 7: not bothered

•

“How often during the last week did you” regarding emotions towards asthma:
o 1: all of the time
o 2: most of the time
o 3: quite often
o 4: some of the time
o 5: once in a while
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o 6: hardly any of the time
o 7: none of the time
•

“How bothered have you been in the last week” generalized
symptoms/sleeping/activities
o 1: extremely bothered
o 2: very bothered
o 3: quite bothered
o 4: somewhat bothered
o 5: bothered a bit
o 6: hardly bothered at all
o 7: not bothered
The caregiver asthma quality of life questionnaire measured caregiver reviews of

activity limitations and emotional aspects of their child’s asthma. This questionnaire is
also scored via Likert scoring with lower scores being representative of increased
caregiver concern:
•

1: all of the time

•

2: most of the time

•

3: quite often

•

4: some of the time

•

5: once in a while

•

6: hardly any of the time

•

7: none of the time
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QOL scores for both patient and caregivers were tallied, and a mean score was derived;
with a lower score being representative of concern or decreased performance due to
asthma.
Table 4C: Patient Reported QOL Scores
QOL Score
Patient Visit 1

Patient Visit,
Subsequent

1

0

2

0

3

2

4

6

1

5

8

2

6

36

1

7

23

2

Table 4D: Caregiver Reported QOL Scores
QOL Score
Patient Visit 1

Patient Visit,
Subsequent

1

0

2

2

3

2

4

4

1

5

8

2

6

27

2

7

33
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Even though written responses were not expected on the caregiver QOL
questionnaire, some parents left written responses regarding their child’s asthma.
•

“I am very upset that she has asthma.”

•

“I don’t get mad at him not his fault.”

•

“Inhalers, neb machine are being used too much, Flovent also.”

•

“If I can’t get out of my black mold apartment won’t be able to control his
asthma.”

•

“I feel hurt because I want her to be ok.”

Asthma action plan (AAP). An AAP allows for the patient to have a written plan of
care at home, school and elsewhere for their asthma. The AAP is written either by
nursing and reviewed by the provider or provider written and then given to the patient.
All 312 patient charts were reviewed for the presence of an AAP.
Table 4E: AAP Presence in Patient Charts
Presence of AAP in
Prior to Inhaler
Technique Education
Chart
Program

After Inhaler
Technique Education
Program

Yes

289

191

No

22

120

Healthcare utilization and absenteeism. Only three patients reported an ER visit in
the past year; 2 of the patients each reporting two visits each. After the chart review, 37
ER visits were noted. Likewise, self-reported urgent care visits were collected, and
families stated that they did not attend any urgent care visits. However, three patients
had an urgent care visit at BMC. Self-reported missed school days were also recorded.
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Twenty-eight missed school days were noted. Self-reported missed workdays were also
noted. Five parental missed workdays were recorded; as well as the loss of one job. All
the above metrics were verbally asked and written down on the inhaler technique
checklist form. Several families did answer with “don’t know” or “unsure” regarding
missed school days.
Analysis, Project Results, and Impact
Demographics. Demographically, the patient ages were all similar to the body of
evidence. In Pittsfield Massachusetts, the asthma prevalence is noted to be 14.4% as
compared to state prevalence at 12.1% (Massachusetts Environmental Public Health
Tracking, 2017). As I reviewed the residences of our patients, our geographic range also
mimicked reported data; a predominance of our patients resides in Pittsfield. This
predominance could be due to geography since CHP-BPA is in Pittsfield.
Patients receiving protocol at practice. As I had reviewed the body of
evidence, I had not noted any mention of patients not receiving the protocol in the
studies. However, not all of our providers participated in the program, and 75% of our
patients did not receive the inhaler technique educational program. Morin, a DNP
candidate in 2012, also conducted a DNP scholarly project regarding inhaler technique
training in Pittsfield, Massachusetts. His program took place at a private pediatric
practice. At the onset of his program, there were two providers (a pediatrician and a
nurse practitioner) and Morin. As noted in his scholarly project; he completed nearly
90% more inhaler technique teaching visits as compared to his physician counterpart.
The nurse practitioner at the practice had resigned just before his implementation (Morin,
2012).
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Barriers reported by CHP-BPA providers to the project included lack of time as
well as the lack of components of the program being endorsed by the American Academy
of Pediatrics. The clinic staff also reported time as being a significant barrier. Upon
further evaluation, the other significant obstacles included the staff forgetting to include
the patient into the IT education protocol; and the medical assistants’ not searching their
provider schedules for asthma protocol patients. The barrier of time was noted in the
literature (Chen et al., 2002) but the other obstacles I found during the implementation
were not found in the literature.
Provider and nursing IT scores. None of the CHP-BPA providers performed
initial IT scoring. All providers, except PD, noted that they did not have the time to teach
their patient's inhaler technique during the patient encounter. Before the nurses
participated in the IT program, their technique was evaluated. All our nurses were able to
complete all eight steps of inhaler technique without an error. This perfect scoring goes
against the evidence. In the evidence noted, most of the providers and nurses do not
know how to perform, evaluate or teach IT (Amirav et al.,1994; Duerden & Price, 2001;
Jones et al., 1995; Sleath et al., 2012; Reznik &Ylie-Rosett, 2014).
Patient inhaler technique. Our patients did not immediately have full
knowledge of how to utilize an inhaler correctly. As well, over half of the patients have
either never utilized an aerochamber or did not use one at all. The body of evidence
noted at least a one to two step improvement in IT post hands-on and verbal education
(Alexander et al., 2016; Burkhart et al., 2005; Foland et al., 2002; Janssen et al., 2003;
Kamps et al., 2000; Levy et al., 2013; Minai et al., 2005; Sleath et al., 2012; Walia et al.,
2006; Zivkovic et al., 2008). Our program also noted this improvement; with five
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children having an increase of eight inhaler technique steps. Once the patients received
an educational session, almost every patient had nearly perfect technique. However, 13
of these patients had return visits with IT performed, and again missed at least three IT
steps. In previous IT studies, retention of IT was noted to drop after only one educational
session; therefore, it was recommended for several sessions to occur (Capanoglu et al.,
2015; Jones et al., 1995; Kamps et al., 2000; Manriquez et al., 2015). Unfortunately,
only 25% of the patients received one inhaler technique evaluation and teaching session.
To improve our patients’ overall asthmatic health; our office always needs to implement
the best practice asthmatic care for all patients; not just when the time allows for it to
occur.
Asthma control and quality of life. The evidence also noted with improved IT
an improvement in asthma control and quality of life was also observed (Alexander et al.,
2016; Burkhart et al., 2005; Carpenter et al., 2015; Carpenter et al., 2016; DeGroot et al.,
2015; Foland et al., 2002; Janssen et al., 2003; Kamps et al., 2002; Levy et al., 2013;
Minai et al., 2004; Sleath et al., 2012; Walia et al., 2006; Zivkovic et al., 2008).
Currently, I am not able to definitively show this same correlation. This is because I had
several missed occurrences for repeat IT program visits. As well, this program only
covered the months from July until the end of October. My program did not have the
same repeat of visits as was noted in the body of evidence. A recommendation would be
to continue to monitor these patients over an extended period to evaluate their asthma
control and the quality of life.
Twenty-six patients reported an ACT of less than 19. A score of less than 19
indicates poor asthma control. Only two times was this score notated and acted upon by
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the provider. Further education of the provider staff needs to occur regarding the use of
this screening tool and how to incorporate it into patient care.
In the measurement of quality of life, only24% of the patients were given an
opportunity to participate in the questionnaire. Further observation and analysis would
be warranted for this group of patients. As well, further provider education must occur.
Again, a few parents noted, “I am scared of my child’s asthma,” and this was not
discussed by the provider or the family during the visit.
Asthma action plan. The asthma action plan is a written at home treatment plan
that allows for a family to be self-efficacious with their asthma treatments; but also know
when to call for help or guidance. Only seven percent of the patients before the program
had a written asthma action plan. After receiving IT education; 38% of the patients had a
scanned asthma action plan present in the EMR. One of the nurses responded by stating,
“Well, I do them all of the time, but I don’t scan them (the action plans) into the chart.”
Most of the providers in the office rely on the nurses to complete these plans for our
patients.
Healthcare utilization and absenteeism. Finally, both missed school days and
parental work days were not accurately reported during this program. As I compared ER
and urgent care visits; the families’ self-reporting numbers were much lower as compared
to the recorded visits. I am concerned that the self-reporting for school and work is also
low. As well, this was a verbal question asked by several different nursing staff members
and providers. This amount of people could have led to the reports that were obtained.
In the future, a checklist system could be considered for families to mark when their child
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is out of school. A partnership with the Pittsfield Public Schools could occur to tabulate
these numbers.
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Chapter 5: Project Sustainability Discussion, Conclusions, and Dissemination
Discussion
Discussion of Project Results
Out of ten pediatric providers, only one provider was 100% vested in the
program. One provider declined to participate at all, and one other provider would only
allow well patients to participate. The remaining providers were actively enrolled in the
program. However, nearly 200 patients were not included in the education program.
This number was mostly attributed to the missed opportunities of either the providers
declining to participate or the remainder of the medical/nursing team missing
opportunities for patient engagement. None of the providers except for myself would
personally teach their patients how to use the inhaler. Our nurses all had 100% correct
inhaler technique.
Only 25% of the asthmatic patients seen between July and October of 2018
received any recorded asthma teaching. Only 49% of these patients knew how to
perform at least seven out of eight inhaler steps correctly. Through the educational
program, 100% of the patients could correctly use an inhaler at the end of one training
session. As was noted, upon a second visit, 69% of the patients receiving a second
screening, again had incorrect inhaler technique. These values mimic the evidence noting
that inhaler technique must be a recurrent educational focus at future patient visits.
Inhaler technique and asthma education cannot remain once a year visit type focus.
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Twenty-six patients scored an 18 or lower on the asthma control test. Only two
times was it recorded in the patient’s record that this score was discussed. A score of 18
or less denotes poor asthma control. As well, the quality of life scores was not often
viewed by the providers. The two most significant reasons for this were: 1- most of the
physicians declined to utilize this questionnaire, and 2- since the copyright for this
questionnaire would not allow for scanning into the EMR all the questionnaires came
directly back to me. After my day was over and the patients had left the office, I noted
the low scores on the quality of life.
This project will have a long-lasting impact on our patients at CHP-BPA. As I
worked with the patients, several noted: “that no one has ever personally shown us how
to use the inhaler.” Other parents noted that they “were scared about their child’s asthma,
but now had a sense that they could talk to our office about their concerns. Many patients
had never used a spacer in the past. Through the generosity of Dr. Lamm, 50 spacers
were purchased for this program. Patients who were not able to afford a spacer due to the
co-pay were now able to have a spacer. As well, several patients were able to have a
spacer both at home as well as at school. I was gone from the office for two weeks
during the implementation project. The spacers were kept in an unlocked drawer in my
desk. Upon my return after each week, the number of spacers in the drawer drastically
decreased. Even though the providers did not fully participate in the program, the
providers realized the importance of the spacers.
Our patients were able to learn how to use their inhalers! Before education, 50
percent of the patients missed three or more steps of inhaler technique. However, after
education, all patient had seven to eight correct inhaler steps. For these patients, we
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fulfilled the ability to teach our patients how to use their inhalers! If this teaching can
move forward to all our patients, the impact on our practice would be phenomenal.
Impact of project results. Two patients were seen at CHP-BPA throughout the
implementation of the project. Each of these patients was seen more than once in the
office. However, each patient had a different trajectory of results.
Patient “I” had three appointments between July and October. At all three
appointments, she received both inhaler technique training as well as the opportunity to
complete ACT and QOL questionnaires. She had a full discussion of her asthma as well
as completion of an asthma action plan for school. One of her appointments was for a
well visit; the others were for asthma follow up. At each visit, “I’s” inhaler technique
improved by one step to eventually having all eight steps correct. At a subsequent visit
after the scholarly project was completed, she again demonstrated her technique and was
immediately able to note that she completed a step incorrectly and verbalized why it was
done incorrectly. She did not require any emergency room or urgent care visits during
the time of the program. She and her mother completed both ACT and QOL
questionnaires at all three visits. Her ACT scores started at 17, increased to 19 and then
decreased to 16. Both she and her mother’s QOL scores increased from five to six.
When asked why she thought her ACT scores decreased, she responded by saying that
she could now tell when she was not feeling well due to her asthma and not be able to be
in gym or sports with her friends due to her asthma. Her mother noted, “she now has the
tools that she needs to be able to be on top of her asthma. We now know when we need
to call for help.”
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Patient “M” had eight visits between July and October of 2018, but only received
the inhaler technique educational program twice. He did not receive the program the
other six times due to either the provider declining the program during the patient visit or
the medical assistant or nursing forgetting to include him into the project. His inhaler
technique decreased in correct steps between the recorded visits one and two. He was
seen two times in the emergency room for his asthma in this period, and his ACT scores
decreased from a 24 to a 10. His reported QOL scores decreased from seven to six;
caregiver scores decreased from seven to four
These two cases show the impact of this inhaler technique education program. As
was seen in the evidence backing this best practice quality initiative program at CHPBPA- this program increases the correct number of steps of inhaler technique and
increases asthma control as well as the quality of life. Only 25% of our patients received
this program at our office. The impact that could have been seen if all 312 patients
received the program could have been enormous.
Discussion of Project Sustainability Plans and Implementation
After careful consideration of the above EBP implementation project data
analysis, the next step in the evidence-based process is formalizing a sustainability plan.
It is ethically required to continue to provide the best, evidence-based care, to the patient
population (O’Mathuna, 2015).
Asthma medical home. CHP-BPA must move past the current care model of
only assessing asthma one time per year or at asthma exacerbation visits. With the clinic
currently being in a state of change, this is an opportune time to implement a new care
protocol for all caregivers. The project has also had the same outcomes as did the body
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of evidence; thus, proving that this project is commendable and needed for our patients.
Repeat encounters with continued emphasis on inhaler technique are required to hone
proper technique and to have improved asthma control. For our patient to own their
asthmatic health; they must be given the required tools to learn about their asthma. The
patients, therefore, must be seen more than once a year or for emergency visits.
While performing the inhaler technique at every patient encounter is
recommended in the body of evidence; this model of patient care was not accepted by
most of the providers and staff at CHP-BPA. One of the most significant barriers noted
by all providers, including me, was the required time. At a well visit, we are only given
20 minutes for ages five to eleven- and thirty-minutes ages twelve and older. This time
does include not only the asthma education but also all other wellness aspects of the
child’s life as well as any other questions the family may have. A sick visit is only
scheduled for 20 minutes. The sick visit intends to only focus on the concern at hand; not
including an additional asthma educational segment.
Both the American Academy of Pediatrics (AAP) and the National Association of
Pediatric Nurse Practitioners (NAPNAP) have separate special interest groups (SIGs)
regarding asthma. Each of these organizations bases their asthma education on the
National Asthma Education and Prevention Program (NAEPP) 2007 Expert Panel
Asthma guidelines.
The American Academy of Pediatrics (AAP) along with the American Asthma
Network (AAN) developed Medical Home Chapter Champions Program on Asthma
(MHCCPA) in 2008. Since that time, the AAP has sought at least one pediatrician per
chapter to be a champion for this program. In an informational website to members of
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the AAP, the AAP has addressed the same barriers to care that was noted in this scholarly
project. For the biggest concern, time, the AAP noted the following:
“Chronic care management visits are a great way to incorporate the six Guidelines
Implementation Panel (GIP) priority messages from the National Heart, Lung, and
Blood Institute (NHLBI) guidelines for optimal asthma care. In a non-acute visit,
asthma control and allergen/irritant exposures can be assessed, asthma severity
and medications adjusted, spirometry obtained (if indicated) and the child's
asthma plan and school medication authorization forms can be completed. For
providers who see many patients with asthma, grouping such visits into a single
clinic day can streamline care flow and enhance staff familiarity with needed
forms and procedures. These visits can be scheduled in longer time slots and
coded for time spent in care. By asking your patient to schedule their asthma
management visit with you before they leave, they are more l0ikely to return, and
you can better predict your workflow” (Planning Care for Children with Asthma
in your Medical Home: Addressing Common Concerns of Primary Care
Providers, AAP 2014).
The AAP recommends asthma visits to the clinic every two to six weeks for
uncontrolled asthma and every three to six months for controlled asthma. At every
patient encounter, the AAP also recommends the following;
•

Discussion of the Asthma Action Plan (AAP)

•

Discussion of asthma medications; how to take and their role in asthma care

•

How to use a spacer and an inhaler

•

Patient to know their asthma triggers; how to self- monitor their care (Key points
for asthma guide implementation, AAP, 2013).
While viewing the NAPNAP asthma SIG website as a non-paying member,

NAPNAP does not have the same explicit guidelines found on their website. The only
inhaler technique information provided is regarding school nurses and asthma care at
school.
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Sustainability plan: asthma medical home at CHP-BPA. A new proposal at
CHP-BPA will be the formulation of asthma medical home care. As noted above, with
all the ongoing change at CHP-BPA, this is an opportune time to implement a new care
model. Even though the evidence supports inhaler technique evaluation at every care
visit, time does not allow for this teaching to feasibly occur. Upon discussion within the
clinic, the providers are agreeable to an implementation of quarterly asthma care
appointments at the clinic.
Each asthmatic patient would be seen four times each calendar year; with one
visit being their yearly well visit appointment. At each of these appointments, the patient
would demonstrate their inhaler technique and then have education given to them
regarding any technique steps missed. The patient would then return demonstration. The
patient and family would also complete the ACT and QOL questionnaires. The provider
would have time to review the questionnaires with the families. Medication management
would also be discussed. Asthma action plans would be formulated. These visits would
be scheduled for 40 minutes; to allow for provider time to fully assess their asthma status.
The social and psychological factors of asthma would also be assessed. A link
between the school and our office should be established. Since the asthma medical home
program would now be solely an office-based program and not have any affiliation with a
teaching university; an IRB would not be required. I would meet with the school nurses
to discuss how we could establish a care team- continuing the work as demonstrated by
Carpenter and partners (2015, 2016) with school-based nursing inhaler technique
training. As well, a system to monitor school absences due to asthma could also be
established rather than an immediate recall system as was used in this scholarly project.
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The evaluation of both patients, as well as patient/caregiver, views life with
asthma is very important. As I saw with a few patients, even though they had an ACT of
27 with near perfect inhaler technique; some patients rated their quality of life as poor.
To improve both asthma as well as ownership of their health- we must address the social
side of asthma.
Fallon Health Care, the ACO for Berkshire County, has a respiratory therapist.
As well, the Berkshire Collaborative, which is a Fallon service, consists of an RN case
manager, social worker as well as a community health worker. We could certainly
consider having an asthma clinic on a select day in the office. We would have the Fallon
workers present to assist with our Fallon ACO patients. We could certainly also reach
out to the other carriers, such as Blue Cross Blue Shield, to inquire if they would be
willing to have case managers on site to assist their patients.
Electronic medical record (EMR) at CHP-BPA. As has been mentioned in the
previous chapters of this project, the current EMR at CHP is not a sophisticated product.
No one can run reliable reports. Practices are not able to determine which patients have a
diagnosis of asthma or even which patients coming to the practice currently have an
asthma diagnosis. The agency is in the process of implementing a new EMR. The EMR
will be in place as of July 2019. This new EMR will have an enhanced reporting feature.
As well, the day to day functionality of the system should prove useful to both the
clinician as well as senior management. Encounters will be documented as a point and
click rather than a free texted field. This will enhance reporting capabilities. As well,
best practices are a function of the EMR. Therefore, providers will have access to asthma
best practices. Since we are still in the process of having the EMR configured for CHP, I
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am hopeful that we will be able to have the ACT as a capturable questionnaire in the
system. We are also hopeful that asthma action plans will also be easy to format within
the system.
Implications of EPIP results to the community/organization, patients, health-care,
nursing and advance practice nursing
The impact of this inhaler technique project along with asthma education and
allowing families to learn how to own their health will be far-reaching. At a subsequent
appointment, one of the mothers of my patients wrote this email to me regarding the
program:
“[My daughter] has been struggling with her asthma for several years. Ending up
on several courses of steroid treatments a year. Her asthma seemed to act up more
in the winter’s months and with any sports activity. Missing days of school, ER
visits and multiple doctor office visits, as well as interfering with her sports.
[My daughter] began seeing Gina Nelson, NP approximately 6 months ago and
we began the asthma treatment program with her. Gina switched [my daughter’s]
inhalers from Flovent to Qvar and added a nightly pill on singulair. We started a
new plan as to when to take her inhalers, for example 20 min before sports. [My
daughter] did step by step training with Gina on how to properly use the inhalers
and chambers.
Since the new treatment plan started [my daughter] asthma symptoms have
significantly improved. She hasn’t needed any courses of steroids, has used the
rescue inhaler very few times and isn’t experiencing interruption with her sports
like she used to.
I would highly recommend this to other parents whose children are suffering from
asthma.”
Mother
This is only one patient account that I received during this project. However, I
was told by many parents during the time that this was the first time that their child was
given guidance on how to use an inhaler. Several parents wrote on their quality of life
forms that they were fearful of their child’s asthma. These comments do not support the
notion that our patients’ asthma is under control. This program is needed and essential
for this community.
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Pittsfield, Massachusetts has an asthma incidence of 14.4% which is nearly
double the incidence of the nation. We also have the fifth highest ER rate for asthma in
the state. Over this past week, CHP has written a press release about this asthma project.
We are hopeful that the efforts that we are going to be engaging in at our practice will
help to decrease the consequences of asthma.
The concept of owning one’s health with asthma is to allocate to the child and
family all the tools that are necessary for the child to function at their greatest physical
and emotional extent without an asthma exacerbation. The children and adolescents
would be allowed to live lives without the fear of asthma. Rather than only treating
asthma during exacerbations and keeping the child and family in an ill state, we need to
start focusing on how to keep the child or adolescent in a well or healthy state, without
exacerbations of their asthma. For advanced practice nurses- this is our mission. We
practice as holistic wellness providers. We need to maintain this state of wellness and
ownership at the forefront of our minds. The American Academy of Pediatrics has a very
well laid out plan of care for an asthma medical home. Their plan is physician led. We
as advanced practice nurses through our practice academies need to also lead the charge
for our patients.
A knowledge gap was found with the implementation of this evidence-based
program. The current evidence states for inhaler technique demonstration and education
to occur at every patient encounter. However, as was noted in this program, this care is
not feasible in a pediatric office with each provider seeing a patient every 20-30 minutes.
I believe that a nursing scientist or PhD will need to come alongside me to discuss the
sustainability plan that is recommended for our office. We would need to work together

68

to discover how quarterly asthma teaching visits would impact upon the asthma outcomes
detailed in this paper. Would the patients and families require fewer or greater visits in
order to achieve the outcomes?
Another knowledge gap involves the new FMHO model and pediatric ownership
of asthmatic health. I plan to work with Maria Donnelley in the future regarding how
families and patients can learn to manage and own their asthmatic health. We will need
to discover if this ownership of asthmatic health would impact their lives further into the
future. Asthma is a progressive disease and can impact a patient’s respiratory and cardiac
health far into the future. Further, if a patient could learn how to own their asthmatic
health, could they also then learn how to own other chronic health issues in the future?
Key Lessons Learned from EPIP Implementation
Many key lessons were learned during this process. First and foremost, all the
providers and nurses deeply care for our patients at CHP-BPA. However, we need to
change the way we are currently practicing on both a business as well as healthcare level
at this time.
CHP-BPA has been operating in a state of change since I joined in 2017. The
practice has merged from being an independent practice for over 40 years to an owned
practice. Furthermore, the clinic went from independent practice to a federally qualified
health center overnight. These are major changes to any practice. Change needs to be
looked at as an opportunity; not an obstacle.
This past fall, CHP hired a new practice manager for CHP-BPA. He was hired
from within CHP, so he is knowledgeable of CHP practice environment as well as
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processes. He has already attempted to work with the staff at all levels to help us to
embrace the changes and to move forward. He is actively involved in the EMR
transformation as well as daily practice. I am very hopeful that his presence will allow
CHP-BPA to evolve into a new revitalized practice.
I was not aware of the power that both our medical assistants as well as nurses
held in the practice until the time of the project. Again, if we as a practice expect
changes to occur, then we must all work as a team. We must all collaborate together;
however, if a care model needs to be implemented then all team members must work
together.
All providers are in favor currently for an asthma medical home. The processes
laid out in the sustainability section have been agreed upon by the providers. With the
upcoming EMR changes, we are in the process of incorporating the new asthma changes
into the practice.
The total amount of expenses for this scholarly project was $10,065.58. The
actualized gross billing for this project was $16,034. If all billing were captured, a profit
from those three months of $5,968.42 would be realized. However, CHP-BPA providers
did not bill to their full extent during the project. At the start of the project, I emailed all
nursing and all providers to make them aware of the additional billing that we would be
able to justifiably utilize due to the increased education and assessments being done at
these visits, including the use of a modifier 25 with well visits. As I reviewed our gross
billing documentation, neither the providers nor nursing fully billed to the greatest extent.
If we had done so, we would have realized a gross billing of $19,983. If all billing were
captured, a profit of $9,917.42 would have been realized; an increase of $3,949.
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Only 119 patients out of 312 patients were a part of the educational program.
These patients totaled a net of 518 separate billable encounters. Three hundred eightytwo visits occurred without the asthma educational program. Counting for only the 27dollar gross billing reimbursement for inhaler technique education, this billable amount
would have captured a gross billing of $10,314. This amount would have been seen in
only three months. Only considering these 312 patients, over a 1-year period of time
with four visits each $33,696 would be gross billed just for inhaler technique education;
not counting for additional billing coding.
CHP-BPA also has the opportunity for performance reimbursement with the
asthmatic population. By maintaining a decreased ratio of quick acting to controller
inhaled medications, written and documented asthma action plans as well as keeping
patients out of the emergency rooms- CHP can receive incentive payments for these
actions. Through the existence of an asthma medical home, all these incentive markers
would be met.
Conclusions
The Breathe in Breathe out Inhaler Technique program at CHP-BPA is a best
practice evidence-based project at CHP-BPA. Major Bourne, in 1996, wrote her master’s
in nursing thesis on inhaler technique. She found that pediatric patients did not use
inhalers correctly. Twenty-three years later, we are finding that patients still do not know
how to use an inhaler correctly. By incorporating an inhaler education program, we
found the same outcomes as did the thirty-one scholarly authors found with inhaler
technique. With inhaler technique hands-on and verbal education, patients can correctly
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utilize an inhaler. It is now time for providers to break the cycle of incorrect inhaler
technique.
I also found that our patients do not have as high of a quality of life with their
asthma as was thought at the start of this project. We must continue with this best
practice program to help our patients learn how to both own their health and to own their
asthma so they can have fewer asthma exacerbations. With this program, we will meet
CHP’s mission statement: “measurably improve the health of Berkshire County,
Massachusetts” with a vision that “Berkshire County’s population will be the healthiest in
Massachusetts” (Community Health Program, 2017).
Recommendations for Dissemination
I submitted an abstract for the background and significance, initial literature
search and proposed implementation plan to Doctors of Nursing Practice 2018
conference. My abstract was accepted for a poster presentation. I presented at the 11th
Annual Doctors of Nursing Practice conference in Palm Springs in September of 2018.
An accompanying concept analysis regarding ownership of adolescent asthmatic
health was also written last year. I submitted this manuscript to Nursing Forum, and it
was accepted for publication in December of 2018. The published manuscript is entitled:
“Ownership of Adolescent Asthma Health: A Concept Analysis.
I submitted an abstract to Sigma Theta Tau for their 45th Biennial Convention in
Washington DC for a podium presentation of this DNP Scholarly Project. My abstract
was accepted, and I plan to present in November of 2019. After presenting at Sigma
Theta Tau, I will prepare a manuscript for publication of this Scholarly Project.
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Figure AA5: Functional Mastery of Health Ownership Schematic
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Figure AA6: Literature Search Flowchart Schematic
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Figure AA7: Clinical Scholar EBP Model in Practice
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Figure AA8: FMHO Model in Practice
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Logic Model for DNP Scholarly Project

Figure AA9: Logic Model Schematic

91

Appendices B:
Evidence Tables and Synthesis Tables
Evaluation Table Inhaler Technique
Used with permission, © 2007 Fineout-Overholt

Table AB1: Evidence Table for DNP Scholarly Project
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Method
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Data
Analysis
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reviews &
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1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
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Study
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Design/
Method
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Limitations:
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Studied and
Their
Definitions

Measurement of
Major Variables

Data
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Study Findings
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evidence + quality [study strengths and
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Authors do not believe publication bias
present

Incorrect MDI steps:
Age 6-18
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-inhalation technique

2000-2015

-holding breath 10
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28 studies
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before 2nd puff
MDI w/spacer:
Correct IT: 0.6%55%
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-shaking inhaler
-waiting 30 seconds
2nd puff
-holding breath 10
seconds
Education:
Teach correct IT=↑
IT regardless

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
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Study
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Data
Analysis
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Education & return
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Telemedicine appt
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Video education ↑ IT,
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5 studies: ↑AC, ↓ER,
↓symptoms, ↓school
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7 studies: ↑ selfmangement, ↑ selfefficacy, ↑AK
RodriguezMartinez, et
al, J of
asthma,
2017, 54(2):
173-185

Systematic
review
instruments
evaluating
MDI IT;
evaluating

None

Level 1
systematic
review

24 studies
included
24 instruments
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Tools utilized
to measure
MDI IT
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checklist

Authors selection
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these included report
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-Boccuti

Author noted limitations:
-methodology used to critique better suited
for scales rather than checklists
Did not include grey literature,
dissertations, unpublished works

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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-Sleath

Child age 1
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-Welch; only age 1-6
Inclusion
articles:

-Kamp

Any article
evaluating tool
MDI use
Exclusion:
If not MDI not
included

Alexander et
al, J of
Asthma,
2016: 53(1),
107-112

Quantify
overconfidence
IT
Measure
number
incorrect
steps
Demogrphic
or clinical
pattern
effect IT

none

Level II
RCT
Same
sample/
method
as 3
minute
video

Inclusion:

IT

IT performed

N=91
Age 7-17

DV: SE

IV: 46 (3
minute asthma
video)

Confidence of
use

IT: steps
perform
correct

Control: 45 (3
minute health
promotion
video)

SE: 1
item
Bursch et
al: how

(same sample
as 3 minute
video)

Scale of
confidence given

TTest/Chi
Square: IT

IT:

P=0.05

-NCC miss 1.8

LR:
baseline
data CC
assess
demo/
clinical
factor
predict
overconfidence

Demographics
CC/NCC:

-CC miss 1.5

-age: p0.28

Continued evidence missed IT and not
able to utilize inhaler correct
Not enough to ask if know how to use
inhaler, CC still missed steps

Limits: only 2 centers, had to miss step IT
to qualify, Hawthorne effect

-gender p0.85
-race p0.48
-AS: p 0.96
-Years asthma: p0.15
ICS: p0.09

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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sure of
IT are
you

Sample/Setting

English/Spanish
speaking/read

-2:a little

MDI user

-3:fairly

Incorrect IT

-4:quite

Mild-severe
asthma

Divide 2
groups
-NCC
answer 14

Measurement of
Major Variables

8 families lost
f/u

-1:not

-5:completely

Major
Variables
Studied and
Their
Definitions

Data
Analysis

(IT
incorrect)

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Demo/clinical not
effect CC/NCC
IT missed:
-shake and hold
breath 10 seconds
both CC/NCC
LR: Clinical
characteristics not
associated incorrect
IT. CC boys more
likely miss/girls
p=0.04

Time: 15
months
Mean age:
IV: 10.9

-CC
answer 5
Amirav et al,
1995, J
Allergy Clin
Immun:
95(4): 818824

Develop,
implement,
evaluate IT
education
pediatric
residency

None

Level II
RCT
-pt ed
IT/spacer
written
Residents
received:

All pediatric
residents in
program years
1-3
Total: 54
residents
20 (37%) 1st
year

IV: continued
education

Pre education/post
education testing

Control: no
further
education past
1st session

IT

Means

IV group:

SD

Pretest IT:

Healthcare providers receiving 1:1
education have improved IT and AK as
compared to those who do not receive

MDI: 3.7/7 correct
13/25 theory correct
Post test: 6.3/7 IT
18/25 theory

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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-theory
IT and
med- AK
25
question
survey;
personal
prescription
practice
-sample
MDI/
spacerdemonstrate IT
with
immediate
feedback

Sample/Setting

18 (33%) 2nd
year
16 (30%) 3rd
year
28 IV
26 control
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Major Variables

Data
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Study Findings
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Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

(p<0.01)
“significantly higher
than control group
per figures”
(no data numerically
represented; able to
view figures)

Excluded if had
AK assessment
year prior

-small
group
session
ER
rotation
1
teacher:2
resident
sessions
discuss

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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RECOMMENDATIONS

all above
and IT

Burkhart, et
al, Nursing
Clinics N
America,
2000, 40:
167-182

Describe
accuracy IT
common
mistakes IT

none

Level II
RCT

Study length: 5
weeks

IT
assessed
pre/post

West Virginia

Teach at
visit 1
then 1-4
weeks
later

RN
assess IT
then
education
Repeat
IT right
away
Same RN
assess
each visit

DV: IT

N=42
Aged 7-11

Does
teaching IT
makes a
difference or
not

IV: education

Mean: 9.6
Asthma dx of at
least 4.6 years

36 brought
MDI to each
visit/ 6 did not.
If did not bring
to at least 2 of 3
visits- not
included in data

DV2: common
mistakes

IT pre/post
intervention

Desc
stats:
mean, SD,
frequency
distribution
McNemar
test for 6
steps IT

Wilcoxon
signedrank test
for change
IT pair
stats
P 0.05
used

Incorrect IT pre/post

Education along with demonstration ↑ IT

92%/19%

Weaknesses: small study size; mostly
white suburb homes

Most common
mistakes:
Not holding breath:
56%
Not waiting 1 minute
between puffs 50%
Inadequate shaking
42%

6/42 (1/7) of children forgot medicationso not part of IT calculation
States that it is a RCT- however
randomization/control is not evident. I
would label this more quasi experimental
Level IV

Not inhaling correct:

Continue to show importance of education
given each visit to improve IT/ correct
mis-steps of IT

42%

Statement of NHLBI guidelines:

Not using spacer
22%
Pre/post Wilcoxin
p<0.0001

McNemar p<0.005
for shake,inhale and
hold breath;

•

Verbal and written guidelines

•

Demonstrate each step

•

Patient demonstrates

•

Assess each visit

•

Provide feedback

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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good: 6/6
steps

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
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RECOMMENDATIONS

Remaining IT steps
not use McNemar
since 100% correct
all steps post assess

-fair:
some
steps

Parental/patient
thoughts on use
inhaler higher than
actual use

-poor: no
steps
Own
spacers/
placebo
inhaler

Carpenter,
et al, J
Asthma,
2015,
52(1): 8187

videos ↑ IT
immediately
& 1 month
Video ↑
confidence IT
& ↑ AC at 1
month

none

Level II,
RCT
Control:
nutrition
video
Exp: IT
video
IT assess
pre/post
video
then 1

Inclusion:
N=91
Age 7-17
English/Spanish
speaking/read

IV: 3 min video
IT. education
Control:3 min
nutritional
educational
video

MDI user
Incorrect IT

DV1: IT

Mild-severe
asthma

DV2: inhaler SE

IV: 46

IT
SE
ACT

Priori
anything
<1 step
change
NS;
N=100
80%
power

IT:

IT & 2nd
outcomes:
linear
mixed
model

CI: 0.53-1.63

control group mean
∆: 0.03

Brief use of videos during a visit can have
↑ IT; however this effect does not last
IT SE did not improve with one video

IV: mean ∆: 1.12

AC did not improve with one video

Mean difference
both: 1.08

Weaknesses:
Lost study funding- could only enroll
91/100 families

P<0.003

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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month
later
Length: 1
month
Given
wallet
card
w/web
site to
watch
video
after
clinic

Sample/Setting

Control: 45
8 families lost
to follow up

Major
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Likert scale of
confidence of
use
AC: ACT

Measurement of
Major Variables

Data
Analysis

Study Findings

1 month f/u IT
control mean ∆:
0.32

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
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RECOMMENDATIONS
Only 42% of subjects using MDI
controller medication- this could have
lessened the AC impact

IV mean ∆: 0.87
Mean difference
both: 0.55

Self efficacy scale used at time of study
had not been reported in the literature

CI: 0.02-1.11
P<0.056

IT SE
Control ∆: 0.10

Video could be effective use of time and
energy in clinic- able to set up and have
family view/ demonstrate IT/ view video
again if needed. Would need to
investigate if able to obtain the video used
in this study. Using new video could alter
the evidence (i.e. making our own video)

IV ∆: 0.28
Change both:
0.38
CI: 0.00-0.76
P<0.052

AC
Control ∆: 1.20
IV ∆: 1.93

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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RECOMMENDATIONS

Mean both:
0.73
CI: 1.02-2.49
P<0.407
Missed steps:
Shaking inhaler
Not holding breath
Kamps, et
al, Ped
Pulm, 2000,
29:39-42

Evaluate
usefulness of
IT instruction
Hypothesis:
receive IT
instruction ↑
IT

none

Level II
RCT
??: IT
info, who
gave
info; time
given
education

Netherlands
Sept 1997-June
1998
Age 1-14
N=95
IV: 66

Control:

-demonstrate IT

IT ed
given at
least
twice
over 4
week
period;

-assess on
checklist
-parents ?? on
instructions
-did parents feel
child did good
IT

IV: only IT
assess, parental
??

IT

Control: 2
education only
sessions, then
assess IT 6
weeks later

60/66 IV group
had already
received IT
training;
hypothesis on IT
instruction could
not be measured

DV: IT

?? data

Contingency
table

Initial- 58% correct
IT/ 97% perceived
correct IT

Chi
square

control:
93% correct IT
p<0.0006

Single short instruction re: IT rarely
successful
Patients whom received ↑ personalized
education with repeated education and
demonstration had ↑ IT
Just verbal education ↓ IT

pharm ed

Weaknesses:

79% correct IT

Intervention group and control groups
were not equal (did not discuss why or if
power analysis was done)

MD/RN ed:
39% correct IT
P<0.0014
?? data:
-Pharm ed: IT
displayed and

Some bias noted in discussion: authors
stated none of children from
disadvantaged background so most likely
no compliance issues- that may not
equate- disadvantaged can have good
compliance and visa versa

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Pharm or
MD/RN

6 weeks
later IT
review

Sample/Setting

Major
Variables
Studied and
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Measurement of
Major Variables

Data
Analysis

Control: 29

reviewed til correct
IT (30 min)

-IT instructed
and reviewed
x2 over 4
weeks

hypothesis:
↑asthma
mgmt.w/ed
benefit pt,
parent,
school,
hospital
budget

none

Level II
RCT

Not placing in mouth
between lips

-6 weeks later
IT assess by
MD

Time=12
months
Control:

Serbia
Recruited at
hospital
admission AE
& ER

asthma
ed at
discharge

Inclusion:
asthma dx, aged
5-18, no comorbidities

Given
“meet

414 initially
assessed- but 26

Very short reference list

Not shaking

-MD/RN office:
verbal instruction
without
demonstration; no
longer than 5 minute
(qualitative data- no
stats given)

Mean 5

AEI (asthma
education
intervention

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
No CI

Missed IT steps:

Aged 1-14

Zivkovic, et
al, World J
Ped, 2008,
4(4): 267274

Study Findings

IV: received
full asthma
school program

Control: usual
instructions

IT
Parental
perception AS
Parental
knowledge of
asthma
Adolescent
knowledge asthma
Adolescent
perception of
asthma

Chisquare &
ANOVA
analyze
between
groups
P<0.05
significant

-compliance↑ pre
69.2%/post 87.6%
p<0.05
-IT: 20.1%/2.3%
p<0.001
Dosage ICS↓
83.6%/71/8%
p<0.001

With education, video and demonstrationincrease in IT, compliance, AK, ↓ fear,
Those patients who received only regular
education- no video or other specialized
education did not show same effect
Weaknesses
Intervention group=231/ control 71- large
difference

-LABA use ↑
8.7%/17.1% p<0.001
Parental concern AS

My project: this study over a 12 month
period of time whereas most studies much

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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-educate
Burkparents
↑AK and
↑QOL

your
asthma””

excluded due to
above

IV:

Mean age 10

-educate
children selfassess and
mgmt.

AEI:

N=

-lecture

Intervention:
231

-video
- 2 ½ day
sessions

Control: 71

Major
Variables
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Definitions
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Major Variables

Data
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Study Findings

↓ concern asthmatic
child: 72.6%-50.5%
p<0.05
-parental AK ↑ IV:
63.1%/82.8% p<0.05
Non-IV group:
parental AK
55.4%/69.3% p>0.05

-??

Adolescent
knowledge
baseline/12 months

All:

IV:↑

PE,
clinical
scoring,
PFT

55.2%-74.1%
p<0.05/

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
shorter duration. As well, more into an
asthma ed program- which practice
working on- however project just IT.
However, could possibly role my project
into the bigger. Must think about if by
doing that would any change be due to the
IT portion or to the full new education
portion.

Non-IV
NS
55.4%-69.3% p>0.05
Adolescent
perception:
AK in IV group:
55.2%/74.1% p<0.05
AK non-IV:
55/4%/69.3% p>0.05

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
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RECOMMENDATIONS

↓Fear of asthma:
35.6%/7.8% p<0.01
↓ concern meds:
31.1%/11.1% p<0.01
Compliance:
66.7%/88.3% p<0.05

Reduced fear:
IV↓
35.6%-7.8% p<0.01

Compliance: ↑
66.7%-88.3% p<0.05

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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first
author

Bourne, J
1996

Purpose of
Study

Examine
effectiveness
teaching tool
for IT

Conceptual
Framework

Design/
Method

Orem

Level IV:
quasiexperimental

Military
pediatric care

Use of IT
checklist

Convenience
sample; 400
asthmatic
children

1:1 MDI
teaching
1st visit:

Sample/Setting

Aged 8-12

12 children
enrolled

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

IT

PFT

PFT

IT checklist

Steps missed

Data
Analysis

Statistical
analysis

Study Findings

All subjects
improved IT post
teaching.
Slow inhalation step
without 100% correct
technique

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Only 1 examiner for IT; author noted
consistency; however potential bias
Some patients used MDI morning prior to
appt; could skew results (mainly PFT)
Education patients for IT ↑ IT

10% IT improvement
PFT did not improve
with subjects

-PFT
-IT eval,
2 puffs
MDI
-PFT
2nd visit 2
weeks
later
-same as
1st visit
but no
teaching

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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first
author

Purpose of
Study

Capanoglu,
et al, J of
Asthma,
2015,
52(8): 838848

Address
problem
correct IT,
adherence to
ICS, effects
of these
problems on
AC

Conceptual
Framework

Design/
Method

None

Level IV
Obs
IT
evaluated
per
evidence
checklist
After ITeducation
2 groups:
IT eval
correct &
IT eval
incorrect
Adherence
ICS:
“good”
use: miss
<2 times
week
“partial”
miss > 2
times
week

Sample/Setting

Major
Variables
Studied and
Their
Definitions

171 children

IT

Aug-Dec 2013

Use of ICS

Ankara, Turkey

AC

Asthma, f/u at
least every 6
months
Exclusion: comorbidities;
only use rescue
MDI

Measurement of
Major Variables

Inhaler use
checklist
?? ICS use, if no:
frequency of use;
reasons nonadherence
AC- ACT
AC- TRACK (<5
yr ??)

Data
Analysis

#/%
discrete
variables
Mean/SD,
IQR
continuous
variables
Chisquare
discrete 2
unrelated
groups
Mannwhitney U
test
constant
variable
non
normally
distributed
AC risk:
logistic
regression
Significance
<p.05

Mean f/u: 10-36
months

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Correct IT and ↑ adherence equated to ↑
AC

AC:

Incorrect IT: 42.2%

40.9% controlled
GINA guidelines

Irregular use: 22.9%

Study Findings

57.9% controlled
ACT/TRACK
Adherence:
77/132: “good”
Irregular: 22%
-partial 1.7%

Education has to be repeated to maintain
IT ; at least 3 times of teaching for IT to
be correct
IT should be evaluated before making
therapy change- AC could ↓ with ↓ IT
Weakness of study: parental report only
on adherence- no other observable metric
for adherence (stated by authors as well)

-poor 21%
Cause irregular:

What steps of IT missed most in study to
look at in CHP-BPA

-forget to take 51.3%
-complicated
technique 25.5%

F/U 3 months after intervention- one of
few studies with follow up

-feel well, don’t need
15.4%
-fear side effect 7.8%
AC:adherence

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Data
Analysis

“poor”
using prn

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Regular: 46.2% vs
irregular 23.1%
p<..01

For stat
analysis
“good=
regular”
& “poor/
partial=
irregular”

MDI/spacer: 119
(69.5%)
DPI: 52 (30)

Correct IT: MDI
68.1% vs DPI 34.6%
p<0.001

Why
miss ??

Missed steps:
-hold breath 10 sec:
24.4%
- shake inhaler 21%

Carpenter,
et al, J of
Ped
Nursing,
(2016), 31:
380-389

tailored video
↑ IT: feasible
for school
RN; improve
IT

none

Level IV
Descr

Convenience
sample

Pilot
study,

7 school RNs
from 7 different
schools

RNs
trained in
IT;
review pt
IT

Children
eligibility:

IV: tailored
video

DV1: IT

IT

Focus group of
school RN
impression of
program

Descriptiv
statsNon parametric
Wilcoxon
signed
rank

MDI w/spacer:
Mean steps correct:
BV: 6.4 AV: 7.6

Video use as education did help to ↑ IT.
Authors have not concluded if just the
video or if combination of rapport with
school RNs and video included

P=0.03
1 month f/u:
100% accuracy

7-17 years old

Only a 5 minute video. Dependent upon
cost, this could easily be feasible within
our practice

p=0.01

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Sample/Setting

Speak English
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Data
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Qual.
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
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weaknesses])
RECOMMENDATIONS

MDI no spacer:

IT score
to video
program

Dx asthma
Using MDI

BV: 4.5 AV: 7.2

Tailored
video to
child w/
self
picked
Avatar

N=25

p<0.01

Mean age 11.5

1 month f/u:

Weaknesses:

Time 1 month

7.3/8 correct

Small sample size

p<0.01

Authors noted that avatars not of different
age groups- may make a difference

video dynamics:

Authors noted, as do I, that school nurses
wanted to be part of study, could have
more interest or buy in with their students
than other school nurses or school
programs

Video
train IT
Recheck
IT after
video

Mean steps correct:

96% chose avatar
same gender
70% same race

Praise given to the children- not just want
did wrong- very important in this age
group

Focus group:
1 month
later redo of
process
Tailor
video
used
again
Focus
group

Overall:
RNs thought feasible
5 minutes to
implement video
with each child

As tech savvy as our population is- this
would be an excellent avenue to look into.
Short implementation time and high yield
of results. Would need to see how we
would be able to acquire this video
program

Children reacted well
to positive vibe from
video

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
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RECOMMENDATIONS

w/school
RNs
-thoughs
-feasible
-resource
Needed
-student
Reaction
Improvements

Chen, et al.,
Ann of
Allergy,
Asthma &
Imm,
(2002), 89:
311-315

Evaluate
skills needed
for IT

none

Level IV,
cross
sectional;
descripttive
correlational

N=132

AK scale

Convenience
sample 8
schools

↑IT r/t asthma
exacerbation, ↑AK,
↑asthma education

Used MDI ≥ 6
mos

Review:

IT
checklist
for IT
eval

Aged 8-13
Persistent
asthma
Taipei

Descriptive stats

Average 5.2 IT
correct

Our population similar; lack of regular f/u
care; only seeking care for exacerbation

t-tests

↑AK=↑IT

linear
regression

↑age= ↑IT

Participants decreased knowledge
regarding asthma and asthma care; same
as our clinic

Linear regression:

Similar barriers- lack of time and
assumption patients know how to perform
IT

½ of participants no
follow up care

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

21% had ≥ 4
asthma attack
over 12 months
39% missed ≥1
day school
9% hospital
admit

Foland, et
al, Cur Ther
Res,
(2002), 62
(2): 142147

Assess AC
and coach
family ↑ IT

none

Level IV
obs/desc
1st visit
then
single
coach
session,
f/u ½
hour visit
2.4
months
later on
average
Evaluate
on
NCLBI:
meds,
PFT, hx

Cleveland OH
July 1999November 2000
N=40
Age range 5-17
Mean age 9.2

Prior to
coaching- 3/26
children proper
IT
Pre: 64 hospital
visit, 17 PICU,
44 ER

Control: initial
IT

Intervention:
one hands on
coaching
session with
measurement of
IT

DV: IT
DV: hospital
visit, ER

IT: pre/post eval
of IT

IT: chi
square

Between 1st and next
visits

1 single hand on and verbal coaching
session improved IT in children

Pre: 3/26 (12%)
perfect IT

Paired
comparison t-test

P: value:

Weaknesses: did not perform study with a
spacer; in actuality have to consider if my
patient population uses spacer at home

Steps correct 1st:
•

1: 92%

•

2: 73%

•

3:27%

•

4:88%

•

5:65%

•

6:42%

•

7:46%

•

8:27%

•

3:p<0.005

•

5:p<0.001

•

6:p<0.001

•

7:p<0.001

•

8p<0.002

Start-finish 34%
improvement (54%
vs 88%)IT:
P<0.001

Authors stated that FEV1, meds and AS
measured each visit; but this data not
given in article.
Authors state that at time of publicationfurther study being performed to see when
children lost any gains with IT.
This study utilized the ability to allow
children to come in on a walk in basis.
This would also be a very interesting
concept to explore if our clinic would be
willing and able to allow this to occur
(support personnel. Possibly, could have

Missed IT steps:

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

PFT all

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Study length:
2.4 months

Measurement of
Major Variables

Steps correct post:
•

1:100%

•

2:96%

•

3:65%

Pre/post

•

4:100%

eval

•

5:88%

•

6:88%

•

7:92%

•

8:69%

IT all

Data
Analysis

Demo by
RT/MD
IT

Study Findings

•

Exhale
fully

•

Breathe
in/hold
breath

•

Exhale
gently

•

Wait 30
seconds
before
next dose

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
hours on certain days of week where this
could occur.)

Statistical testing stated- only p values
given. Not given further statistics

FEV & AS
Janssen, et
al, Eur J
Gen Prac,
2003, 9,
143-145

Evaluate the
IT of
asthmatic
children in
gen practice

none

Level IV
Obs/Descriptive

7 practices

IT

Netherlands

Past education

114 invited
IT assess

N=72

IT eval
by train
MD:
adequate
not
adequate

Aged 6-16
Mean:10

IT through
assessment trained
MD

Contingency
table

Correct:incorrect IT

Chisquare test

Most commonfailure to exhale

MannWhitney
test

Waiting 30 seconds
next dose

p<0.05
significant

25%/75%

90% received some
instruction at time of
script; only 15%
received repeated
instruction

Most children and parents consider their
IT is adequate when in reality this
generally is not the case. This study 75%
of children could not use correctly even
though thought had good technique
In questionnaire- most children received
some form of education at time of MDI
being prescribed- but did not receive
education again. In this study, again, 75%
children poor IT
The more education/instruction given the
better the IT

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

Adequate
all steps
correct
Not
adequate:
miss
steps

??
Age,sex,
inhaler
type,
whom
Rx,
whom
gave ed

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Repeat instruction
↑IT: p=0.014
Instructor/method no
significance
5 years use or more
↑IT: p=0.008
All children and
parents scored IT as
adequate even with
75% missing steps

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Age, type of instructor not have effect on
IT
AC and length of use of inhaler effects IT
My practice- most patient state can use
inhaler- but we are not currently eval IT. I
would be very interested to incorporate
this knowledge into my project as well

Mann Whitney
Age 0.577
User duration 0.008
Chi square:
Sex 0.891

Parent/

Instructor (type of
medical provider)

Child
opinion
IT

0.590
AC on IT p=0.014

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Jones, et al,
Ann of
Emergency
Med, 1995,
26(3): 309312.

Purpose of
Study

Evaluate
ability ER
providers &
pt
demonstrate
correct IT

Conceptual
Framework

Design/
Method

Sample/Setting

none

Prospective cross
sectional

5 teaching
hospitals
Michigan

Level IV

N=185 health
care providers
(60 ER house
staff; 50 ER
attending; 75
ED RN)

Given
placebo
inhalerdemonstrate IT;
no ability
to use
resource
book

Major
Variables
Studied and
Their
Definitions
Knowledge of
IT: ability to
demonstrate
correct IT

Measurement of
Major Variables

Number correct IT
steps

Data
Analysis

2 tailed
fisher
exact
contingnecy
table

41% providers 5/6
steps correct

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Provides & patients do not have correct IT
greater than half the time

49% patients 5/6
steps correct

No significant difference between types of
health care providers IT knowledge

p>0.05

Decrease spacer knowledge

P<0.05
significant

p=.11 difference
health care providers

Study Findings

15% providers/17%
patients estimate
amount medication in
canister

N=100 ER pt
asthma, MDI 3
months

90% providers knew
about spacer
28% describe spacer
Levy, et al,
Prim Care
Respir J,
2013,
22(4): 406411.

Relationship:
AC:IT

none

Level IV
Obs
Retrospective
chart
review

??
IT eval
with

UK

IV: education

2009

AC

Age: <16->76

DV: IT

N=3981

DV: AC

All IMPACT
practices select
pt

IT 3 visits failed:

↓IT=↓AC

Chi
Square

58, 52, 38% incorrect
IT on 3 attempts

Need to assess IT in order to order and
continue with MDI treatment

OR

-flow

Spacer use ↑IT

-synchronized
breathing

Used in-check dial for IT assess

IT

-breath-holding

-BTS 1-3
AC:IT:

Weakness: no control group
Since retrospective not able to ascertain if
abiding by guidelines or if noncompliance
issue

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

Sample/Setting

education
after

-no AC review
15 months

AC
GINA
strategy

-no IT assess 15
months

IT assess
AIM:
color
coded
response
to IT
At least 2
AIM
meetings
and
education
In-check
device
utilized

-not compliant
meds
-using >SABA
12 months
-hospital admit
12 months

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

-Incorrect IT 4x
higher uncontrolled
asthma; 2x in
partially controlled
Chi square:
1+asthma
exacerbation: fail IT
(68%)
P=0.03
Short course steroids:
↓IT (67%), p<0.05
OR 0.50-0.89
Use of spacer:↑IT
(68% vs 51%)
p<0.0001 Chi square
value 20.16

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Project: office has availability to in-check
dial- 2nd study to utilize

Very important to consider this study with
project—several patients have less than
desirable asthma control- we do not
currently measure IT. Again, another
study noting improved AC with improved
IT

Several patients in practice have oral
steroids at least once per year- do not
routinely check IT

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Minai, et al,
Resp Care,
2004,
49(7): 600606

2nd article on
PACT in
Ohio
sustainability
of IT/ PFT↑/
↑ asthma
outcomes

Conceptual
Framework

Design/
Method

Sample/Setting

None

Level IV
Obs

Time: mean 9.8
months

PFT each
visit

PACT clinic:

PFT & FEV1
(pulm fuction)

Inclusion:

AS

RT IT
ed/

N=60

review

≥4 years

AS: likert
1-4

Excessive ER
visits

PFT
likert 1-4

Difficult
asthma

2 data
times:

MDI prescribed

T1-1st
visit
T2: 2nd
visit

Major
Variables
Studied and
Their
Definitions
IV: PACT to
individualize tx

Measurement of
Major Variables

IT

Data
Analysis

Para &
non- parametric
testing
Descriptive stats
variables

Study Findings

T1:T2 comparison:
-IT correct: 53%/81%
-PFT severity:
2.4/2.1
-AS score: 2.6/2.3
FEV1 87/87

t-test
pulmonary
variables
between 2
visits
1-way
analysis
variance
and linear
regression
for IT&
other
pulm
measures

FVC: 92/95

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
With repeated demonstration and
education ↑IT
FEV and PFT not affected; authors ? if
would see improved PFT after further time
Weaknesses: no control group
Small number
f/u was determined by AS- so some
children received ↑ ed compared to others

FEF: 70/69
T score:
MDI: ↑ p0.001

some of our patients would also receive ↑
ed than others; ? possibility of having
individualized education

AS: p0.10
PFT: 0.10
FEV1: 0.96
FVC: 0.15
FEF 0.87

Chisquare
expect
and
observed

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

frequencies

Stat significance
at
p<0.005
Munzenber
-ger, et al; J
of Asthma
(2007) 44,
769-773

Evaluate %
IT retained
between
visits

none

2 group
parallel
nonrandomized open
study

Asthma/allegy
clinic Michigan

% correct IT
between visits

Pt aged 4-18

% correct
individual
component IT
between visits

Visit 1:
education
program
IT
evaluated
by
pharmD

Inhaler use
checklist

% score
% item

Group 1: mean 2.7
months to f/u

t test

Group 2: mean 3.8
months to f/u

72 patients

Mann
Whitney
U test

Group 2 older;
asthma longer; ↑ time
used MDI

Group 1: MDI
only (24 pt)

Fisher
exact test

Group 1 ↑ spacer use

Group 2: MDI
& Discus use
(48 pt)

P<0.05
significant

Jan 2002-June
2005

Group 1 ↓ AS
Overall ↓ IT to f/u
appt: 60% ↓ IT

Authors compared their results to Kampswith Kamps study ↑ IT with visits- one
thought ↑ younger children in this study
with adult supervision; vs older children
alone
Author noted bias in groups- MD
preference to treatment required open non
randomized design- could have influenced
outcomes
Utilized an 8 item inhaler use checklist;
authors noted if used a different checklist
outcomes could have been different

Group 1: 12/24
correct IT
Group 2: 14/48
correct IT
Each component IT:

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

No significance
between group 1 & 2
Even with 1 intense
education session,
↓IT by next visit
Hands on with verbal
education
recommended
Sleath, et al
(2011).
Pediatrics
127(4):
642-650

Describe IT
children;
Extent
providers
demo IT

Social
cognitive
theory

Level IV
Descriptive
IT review
child
Audio of
visit-to
eval if
provider
demo IT

5 pediatric
practices NC
Aged 5-18;
speak English

IV: provider
education

DV: IT

Medication
recorded
AS reviewed by
pulm MD

N=291 children
Using MDI
Classified into
AS categories
Providers as
well in study
N=41 providers
(4NP)

IT-assessment by
team
Provider
demo/education by
audiotape

Descriptive states
for
variables
Bivariate
stats
between
variables:
t-test,
pearson
if ↑
bivariate
then
multivariate
analysis

8.1% correct IT
patient (pearson r
0.20 p<0.001)

Providers asked 5.4%
MDI users/2.3%
children w/missed
steps IT to demo IT
to them
Provider demo IT:
3.8% all MDI/ 2.3%
poor IT children

Shows use of inter/intra collaboration in
order to increase IT both child/provider

Provider needs to know how to utilize as
well

These results most likely very common in
most clinics
Self efficacy: ↑SE=↑behavior (use MDI,
undertake behavior). Model use of MDI
can ↑ SE

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Turkeli, et
al, Tuberk
Toraks,
2016,
64(2), 105111

Evaluate
influence
standardized
education on
IT & AC;
identify
factors assoc
w/ results

Conceptual
Framework

Design/
Method

none

Level III
Cohort
Follow 2
months
IT
education
Hands on
demo IT
Child
demo IT
Return
education
Return IT
demo
RTC 2
months
later to
demo IT

Sample/Setting

Uncontrolled
asthmatic
children
38 children
aged 2.5- 13
Recruited
pediatric
allergy/
pulmonary
office
Use
MDI/spacer
Exclusion:
Co-morbidity;
already
received AE

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

ASS: asthma
symptoms
score:
assessment
daily asthma
symptoms

Demographics

AC

ACQ (aka ACT)

IT

IT: inhaler use
checklist

Parent
demographics
Asthma symptom
score (ASS)

Data
Analysis

Mean/SD
demographic
info
ASS,
ACQ
paired t
test

Study Findings

Mean duration
asthma 21 months
Mean months MDI
use 17.4
IT:

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Common missed IT steps as seen in other
studies
2 step improvement in IT with education
(verbal, hands on redemonstrations)- one
of few studies listing step increase with
education

Before education:
4.9 (1.3 SD)

IT
pearson
chi square

After education:

P<0.05
significant

P<0.001

Decreased asthma severity noted with
inhaler technique education

7.8 (0.4 SD) steps

ASS:
Before education:
4.3 (3.6 SD)
After education:
0.2 (O.7 SD)
P<0.001
Errors IT steps before
education:
Lack mouth rinsing
78.9%

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Lack exhaling before
inhalation (65.8%)
Not shaking inhaler
(60.5%)
Most common errors
IT steps after
education:
Not shaking inhaler
Not exhaling before
inhalation
Lack rinsing mouth
(all 2.6% of cohort)
Deerojanawong, et
al.,Asian
Pac J
Allergy &
Immun.,
2009, 27:
87-93

Evaluation of
MDI use w/
& w/o spacer.
Identify skills
required for
MDI use

none

Level IV
descriptive prospective
Thailand
Measure
IT with
IT checklist

Asthmatic
children outpatient setting
Jan-Dec 2004
93 children
Ages 3-14

IV: education
IT

IT

Mean %

Factors correct IT:

Chi
Square

-MDI given by
caregiver: 28%
correct IT

ANOVA

->age 10: 66%
correct IT

Author noted bias: children selected
mostly had controlled asthma within the
clinic
Combination of MDI with spacers and
without spacers; those w/spacers had
improved IT

-first instruction
trained HCP: 28%
-frequency ITT: once
33%

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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-frequency ITT:
twice: 47%

Most frequent error:
inhalation error
Walia, et al,
Ped Pulm,
2006, 41:
1082-1087

Assess IT
w/spacer to
pediatric
chest clinic
and
determine
factors
associated
with incorrect
IT

none

Level IV
Descriput
-ive
Cross
Sectional
North
India
IT form
to patient
w/retrun
demo
f/u every
12 weeks
stable

↓ AC f/u
every 2-4
wks

July 2004-Dec
2004
N=213
Age 5months18 years
152 urban/61
rural
IT eval
Exclusions: not
using MDI,
newly referred
not previously
receiving IT
instruction,
acute
exacerbation

IV: education

IT
Care of
inhaler/spacer

Number
(%) or
mean
(SD)

88.3% correct IT

Chisquare test
for IT

-rural/urban 0.422

P<0.05
significant

-age p=0.021
-gender 0.239

-materanl education
0.673
-paternal education
0.359

This clinic had excellent results in regards
to relatively good IT among patients.
Clinic also had set program of frequent IT
education with patients
Stated weakness: no control group without
regular IT training
Only allowed in patients who had
originally received education from their
clinic- if newly referred excluded- could
be bias with that

-income 0.979
-AS 0.445
-duration spacer use
0.013

Acute exacerbation excluded- again could
be bias with those results- their IT may be
faulty which is causing them to have
exacerbation

-MD assess AC
0.909
1 mis-step 7%
Miss all 4.2%

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Most common
mistake:
Cap removal
Shake inhaler
Hold inhaler
Exhale/mouth
Inhale
↑IT=↑AC p<0.009
8 pt never cleaned
device
5 changed spacer >1
year
7 never checked
inhaler empty

Schmier et
al (2007)
Annals
Allergy,
Asthma
&Immunol
ogy 98:
245-253

Evaluate
asthma
activity
limitations &
productivity
children and
caregivers

none

Crosssectional
cohort

Sept 1, 2005December 31,
2005

Surveys
sent to
families

John Hopkins
Asthmatic
pediatric
patients listed
from previous
research

AC- perception
of AC
QOL
perception
Missed
school/work
days
ER/care visit

ACT

Means

Pediatric asthma
QOL

SD
Cronbach
(QOL)

HWQ
questionnaire
Parental: asthma
QOL caregiver
survey

Bivariate
analysis
(QOL,
cost:

Past year caregiver
survey:
-45% minor
difficulty with
asthma; however

Very needed information correlating
asthma severity to school and ED and
QOL. With improved asthma, QOL is
improved

-70% asthma
exacerbation
-32% ED visit

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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239 children:

HWQ parental

131 age 4-11

Surveys on
school/work
missed/ER health
visits

108 age 12-18

Costs due to
asthma survey

Data
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Parametric and
nonparametric
testing
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-6% hospitalization
-58% controller
medication past week
-90% rescue
medication
ACT scoring
(<19=uncontrolled)
-mean 15.3: 16
adolescent; 14.6
younger child
Adolescent <19 ACT
increased impairment
QOL (mean SD):
-symptoms 4.2
-emotions 4.8
-activities 4.8
-overall 4.5
(p <0.001)
Work/School:
Control asthma: 3.5%
missed 1 day

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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Uncontrolled asthma:
34% reported
missing 1 day
(p<0.001)
Arrive 1 hour late:
Controlled: 3.5% vs
uncontrolled 34%
p<0.001)
Left school early:
Controlled 1.8% vs
uncontrolled 21.3% p
.003)
Developed asthma sx
at school:
Controlled 29.3% vs
uncontrolled 76.6%
p<0.001)
Parental work:
Reported more
missed work days
with asthma:
Missed due asthma
2.5 days vs not
asthma 1.5 p .08

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

HWQ: controlled
asthma improved
productivity (SD):
control vs
uncontrolled
-self domain 1.3/2.1
-other domain 1.3/1.9
-concentration
2.1/1.8
-irritabilility 2.2/2.4
P .01
Resource use/cost:
means:
Asthma exacerbation:
0.7
ED: 0.32
Overnight hospital:
0.06
Asthma exacerbation
uncontrolled vs
controlled:
0.83 vs 0.59 p.001
ED visits:

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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0.50 vs 0.17 p.001
Overnight hospital:
0.10 vs 0.03 p .04
Out of pocket cost
(2005 dollars):
$997 expenses & lost
income
58% cost OOP
medication
Total wages/benefits
/out of pocket 00lost:
1400 uncontrolled vs
600 controlled

Manriquez
et al J Bras
Pneumol
(2015)
41(5): 405409

Assess IT
ped/adult
pt;dtm most
common
errors;
compare
results

none

Descripttive cross
sectional
Regular
appt; 1
week
later IT
reassess
without
further
education

Chile

IT

Viewed IT

March-May
2014

errors

Inhaler use
checklist for errors

Aged 5-90
(pedi 5-18;
adult 19-90)
270 total; 7
excluded comorbidity;

Descriptive stats
% correct
% error 2
groups
evaluated
by
equivaleence test

Correct IT:
73.4% pedi correct
9i.1% adult correct

Most of pediatric patient had better IT
compared to adults- however, study did
not delve into why they may have noted
(education? Longer time of use with
poorer IT?)

Incorrect IT:
26.6% pedi
90.6% adult

Study did not look at IT after further
education sessions- only 1 week after last
office visit

Error:

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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P<0.05
significant
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Fail hold breath 10
sec: 8.1%

128 adult

Fail continue inhale
after actuation ihaler
6.1%

Regular asthma
f/u; have MDI
script; received
IT teaching

Fail exhale before
using inhaler: 3.7%

Exclusion: resp
co-morbidity;
physical
ailment ↓ IT

Error adult:
Fail exhale before
using inhaler 53.1%
Fail hold breath 10
sec 46%
Fail 1 puff at a time
28%

Reznik, et
al, 2013,
Clin
Pediatrics,
53(3): 270276

Study
pediatric
provider
practices
demo/assess
IT;
differences
between res
& attending;
perceived

None

Level IV
Crosssectional
survey
Oct
2011March
2012

Residents &
attending MDs
3 pedi practices
Bronx NY= 114
providers
Residents:73
Attendings:40
NP: 1

Demo IT
Teach IT
Assess IT

Survey collection

Mean/SD
categories
Difference
proportion
Fisher
test/ chi
square

92/112 87% demo IT
Attending use
illustration: 9/37
(residents 3/55) 24%
vs 6% p=.01
Demo IT if asthma
not controlled:

Previous study by authors reported 85%
patients incorrect IT despite previous
education
Authors noted use of community health
worker as possible way to improve
Limitations:
Did not assess providers own knowledge
of IT

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

barriers to
education

Conceptual
Framework

Design/
Method

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Pedi res
&
attending
Bronx

Attending: 25/37
68%

3 pedi
practices
as
training
sites

P=.05

11 item
??:
-demo IT
-how/
when
demo IT
-assess
IT
- use IUC
-barriers

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
-in inner city clinic- possibly not
generalizable results

Resident: 27/57 47%

Pt not bring MDI:
98/114 86%
None utilized IUC
When assess IT:
-every visit 10/75
13%
Common barriers:
-no MDI: 66%
-lack of time 50%
-↓ knowledge IUC
28%
-↓ pt/family interest
1/41 attendings:
11/72 residents: 2.4%
vs 15%
Overcome barriers:
-provide MDI n=55

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

-provide training to
providers n=13
-embedded educator
-more clinic time
-handouts

deGroot et
al, Acta
Paed,
(2014)104:
916-921.

Investigate
causes
uncontrolled
asthma in
referred
patient

None

Level IV
retrospective
chart
review
1/200512/2009

Aged 5-17
referred to
pulmonary
specialty

Asthma
exacerbation:
seeking care &
rescue med

N=142

Asthma
severity: ACT

Netherlands

IT: review
every visit
Adherence:
every visit
question of med
taking

Vital signs;
Daily meds
Asthma
exacerbation
Asthma severity

Normal
distribute
by parametric;
nonnormal
distribute
by nonparametric
metric

Only 4 patients met
guidelines for true
treatment resistant
asthma; other 138
due to
“shortcomings”
asthma management

Chart review demonstrates multifactorial
reasons for asthma treatment, compliance
and severity
IT a part of asthma control

Poor IT: 7.8%
Nonadherence 37%

Environmental
triggers: in
home review of
asthma triggers
Co-morbidities
diagnosis listed

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Duerden, et
al, Dis
Mgmt &
Health
Outcomes,
9(2)75-87.

Purpose of
Study

Literature
review

Conceptual
Framework

Design/
Method

Sample/Setting

none

Lit
Review

Database
review

Level VI
IT
Compliance
AK

Major
Variables
Studied and
Their
Definitions
Lit review of
IT; compliance,
AK

Measurement of
Major Variables

Lit review of IT;
compliance, AK

Data
Analysis

none

Study Findings

Poor IT:
-82%incorrect
-56% accuat6ed MDI
too early/late

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Poor IT assoc w/ poor AC
Providers do not know how to use inhalers
and benefit from education and repeat
education

-79% made errors on
8 point assessment
-89% error inhalation

MD/RN poor IT:
-15%RN correct IT
-28% MD correct IT
Role of training IT:
-communication
correct IT and
monitor IT
-10% correct IT selfmgmt vs 51% with
verbal/written
education
Provider education:
-after 1-2 teaching
seesion:

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Citation:
first
author

Purpose of
Study

Conceptual
Framework

Design/
Method

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Pre 3/7/7 steps
correct/post 6.3/7
step corect

Pedersen, et
al, Primary
Care Resp
J, 2010:
209-216

Expert
review of
ADMIT
series &
pediatric IT

None

Level VI
Review
of
research
ADMIT
series

ADMIT series
review

Inhaled med ↑ work
at lung, ↓ time
medication action, ↓
systemic effect
Discussion of droplet
deposition oral
pharyx/esophagus:
larger droplet size=↑
deposition. Child’s
airway=↑ deposition
Common errors:
Coordination
breathing
50% school aged
children ↓ benefit
med d/t incorrect IT
Spacers ↓ deposition
in oral pharynx &
esophagus (80% ↓
30%); ↑ IT
IT needs to be taught;
teaching each visit

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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first
author

Purpose of
Study

Conceptual
Framework

Design/
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Major
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Major Variables
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Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

After 3 instructions:
98% MDI correct IT;
after 2 instructions
90% correct MDI IT
Teaching each visit
to ↓ knowledge loss
of IT

Price et al,
Resp Med,
2013, 107:
37-46

Expert
review of
literature

None

Level VI
Review
of
literature/
expert
opinion

Review of 92
published
papers
regarding
inhaler
competence

-inhalers not used
correctly 14-90%
time

Patients do not have correct IT
Necessary to include healthcare provider
education for IT and to teach IT

VT & hand on
together ↑ IT

Each device own IT instructions

-multiple factors
incorrect IT

Verbal plus hands on training reinforces
IT

--device (multiple,
used differently
--patient:
noncompliant,
incorrect IT
-- healthcare
provider: does not
know IT; does not
teach IT

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire
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first
author

Purpose of
Study

Conceptual
Framework

Design/
Method
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Major
Variables
Studied and
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Definitions

Measurement of
Major Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Addition of
healthcare provider
IT education increase
knowledge IT; how
to teach IT

Morin, R
(2012).

Improve
pediatric
MDI IT

Orem

DNP
scholarly
project
Pre/post
test IT
IT
checklist
Pt
demonstrate IT

Pittsfield, MA

IT

IT checklist

Convenience
sample

Healthcare
providers ↑ IT
teaching

Observation health
care provider
teaching amount

11 weeks
N-118

Descripttive stats

111 teaching
episodes DNP
candidate
7 teaching episodes
MD

Same city as my DNP scholarly project.
Not necessarily same socioeconomic
DNP student higher engagement than
clinic staff for teaching moments

11% IT correct to
100% correct post
education; mean 2.3
improved steps

-receive
teaching
-redemonstrate IT

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Levels of Evidence
Table AB2: Levels of Evidence
Level of Evidence

Type of Study

Number of Studies

I

Systematic Review

2

II

RCT

6

III

Cohort

1

IV

18

VI

Observational/Descriptive/Prospective
Cross Sectional/Retrospective Chart
Review
Literature Review

VII

DNP Scholarly Project

1

3

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Verbal inhaler technique/Hands on technique/Return Demonstration with outcomes Synthesis Table
Table AB3: Verbal Inhaler Technique/Hands on Technique/Return Demonstration with Outcomes Synthesis Table
Articl
e

1
3
4
5
6
7
8
9
11
12
13
14
16
17
18
19
20
21
22
24
30

Vide
o

√

√

Hands
On
Educatio
n

Verbal
Educatio
n

√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

Placeb
o
Device

√

√

Return
Demonstratio
n

√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

Outside
clinic IT
educatio
n

√

√
√

Inhaler
Techniqu
e

↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
=
↑
↑

Asthm
a
Contro
l

Asthma
Knowledg
e

Medicine
Complianc
e

Fear
Asthm
a

↑
↑

Misse
d
Schoo
l

ER
us
e

↓
↓

↑
↑

↑

↑

↑

↑
↑
↑
↑
↑

↑

↑

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Collaborative Team Synthesis Table
Table AB4: Collaborative Team Synthesis Table
Article
7
13
17

Collaborative Effort
Respiratory Therapy
Pharmacy
Respiratory Therapy

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Length of Intervention and Sustainability Synthesis Table
Table AB5: Length of Intervention and Sustainability Synthesis Table
Article
1
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
24
30

Length of Intervention
15 months
5 weeks
4 months
4 weeks
4 weeks
3 months
12 months
4 months
4 weeks
4 weeks
Not stated
4 months
3 years
4 weeks
3 years
3 months
2 months
12 months
Not measured
2 months
11 weeks

Sustainability measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
3 years
Continuation of PACT study
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured
Not measured

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Provider Knowledge of Inhaler Technique
Table AB6: Provider Knowledge of Inhaler Technique Synthesis Table
Article
2
3
7
13
19
23
25

Provider Knew How to Use/Teach Inhaler Technique
NO
NO
NO
NO
NO
NO
NO

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Tools Utilized During Implementation
Table AB7: Tools Utilized During Implementation Synthesis Table
Article

1
2
4
6
7
8
9
10
11
12
13
14
16
17
19
20
21
22
26
30

Asthma
Control
Test

Inhaler
Use
Checklist

Asthma Quality of
Life

Asthma Action
Plan

√

√
√
√

Spirometry

Education

√
√
√
√

√
√
√
√
√
√

√
√
√
√

√

√
√

√
√
√
√
√
√
√

√
√

√

√

√

√
√

√

√
√
√
√

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Correct Inhaler Technique Steps
Table AB8: Correct Inhaler Technique Steps Synthesis Table
Article
Remove
Shake
Exhale
Place
Cap
Inhaler/Insert Completely Mouthpiece
into Spacer
in mouth
in-between
lips
3
√
6
√
√
7
√
√
9
√
√
10
√
13
√
14
√
19
√
20
√
√
22
√
√
√
√
24

Press
canister
Down
Once

Breathe in
Slowly &
Completely;
hold breath
10 seconds
√
√
√
√
√
√
√

Exhale
Gently

Wait 30
seconds
before
next dose

√
√

√

1: Gillette et al. (2016); 2: Rodriguez-Martinez et al. (2017); 3: Alexander et al. (2016); 4: Amirav et al. (1994); 5: Burkhart et al. (2000); 6: Carpenter et al. (2015); 7:
Kamps et al. (2000); 8: Zivkovic et al. (2008); 9: Bourne (1996); 10: Capanoglu et al. (2015); 11: Carpenter et al. (2016); 12: Chen et al. (2002); 13: Foland et al. (2002);
14: Janssen et al. (2003); 15: Jones et al. (1995); 16: Levy et al. (2013); 17: Minai et al. (2004); 18: Munzenberger et al. (2007); 19: Sleath et al. (2011); 20: Turkeli et al.
(2016); 21: Deerojanawong et al. (2009); 22: Walia et al. (2006); 23: Schmier et al. (2007); 24: Manriquez et al. (2015); 25: Reznik et al. (2013); 26: deGroot et al.
(2014); 27: Duerden, et al. (2001); 28: Pedersen et al. (2010); 29: Price et al. (2013); 30: Morin, 2012
AC: asthma control; ACT: asthma control test; AE: asthma education; AQLQ: asthma quality of life questionnaire; AS: asthma severity; AV: after video; BV: before
video; CC: completely confident; DV: dependent variable; DX: diagnosis; FEV1: forced expiratory volume 1 second; ER: emergency room; FVC: forced vital
capacity; GINA: global initiative for asthma; GT: good inhaler technique; HOH: hard of hearing; ICS: inhaled corticosteroid; IMPACT: Improving the Management
of Patients Asthma and COPD Treatment; IT: inhaler technique; IV: independent variable; MDI: metered dose inhaler; NC: no change; NCC: not completely confident;
NS: no significance; Obs: observational; PACT: pediatric asthma clinic trial; PE: physical exam; PIF: peak inspiratory flow; PFT: pulmonary function test; pop:
population; PP: parental perception RCT: randomized controlled study; RT: respiratory therapist; RTC: return to clinic; SE: self-efficacy; VT: verbal inhaler training;
∆ change; ??: questionnaire

Appendix C: Chapter 3
Table AC1: Full Implementation Plan
Intervention
Evidence Support

EBP instruction to staff

Clinic staff must know
difference between
research and EBP and
how EBP drives
change (Melnyk, B &
Fineout-Overholt, E,
2015)

Brainstorming session
with nursing and
providers

Brainstorming is a
quality improvement
marker (American
Society of Quality:
Brainstorming, 2017)

Respiratory Therapy
teaching inhaler
technique PD; then
teaching to
providers/nursing

7,13,17

•

Obtain Asthma
Action Plan
(AAP)

1-31

Who

Where

Pre-Implementation Steps
PD
CHP-BPA
BPA MDs
library
BPA NPs
BPA
nursing
BPA MAs

How
•
•
•
•
•
•

PD
BPA MDs
BPA NPs
BPA
nursing
BPA MAs
Hadley
PD
BPA NPs
BPA
nursing
Respiratory
therapy
PD

CHP-BPA
library

CHP-BPA
library

•
•
•
•

•
•
•

Face to face discussion
Powerpoint of EBP basics
Clinical Scholar EBP model
Education provided by PD to clinic staff
To discuss each step of EBP; relate to
practice
PDF handouts created for each step in
EBP model
Allowed for time for questions/answers
Face to face discussion
Whiteboard
Journal for notes during discussions by
PD

PD met with RT for inhaler training
PD met with each nurse individually to
train for both inhaler technique and well
as inhaler technique checklist2,4,6,7-9,1114,16-17,19,21-22,26,30

CHP-BPA
PD home
Asthma
coalition
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•

Acquired from State of Massachusetts
and American Lung2,4,6,13,17

•

Placed into asthma packets kept in PD
office

Intervention

Evidence Support

Who

•

Obtain Asthma
Control Test
(ACT) form
• Obtain pediatric
quality of life
(QOL) form
• Obtain Inhaler
Use checklist
form
• Construct
verification
forms (ER/urgent
care utilization,
missed school
days/work days,
AAP completion)
QI/QA assessement
QI/QA processes
improve EBP
• PDSA
• 8 dimensions
AHRQ: PDSA, 2017
IHI: PDSA 2017
Reed & Carol, 2015
Review
barriers/facilitators
ASQ: 8 dimensions
2017

First Vist:
• ACT
• Pediatric QOL

1-31

Where
American
Lung
Association

PD
BPA MDs
BPA NPs
BPA
nursing
BPA MAs
Hadley

CHP-BPA
library

How
•

Placed in unit protocol handbook in
Carol’s office

•
•
•
•

Face: face meeting
Whiteboard
Journaling by PD
Education by PD to nursing and provider
staff regarding QI/QA process (verbal
and written)
Notebook kept in library for further
comments, thoughts, reflections from
staff- encouragement for staff to utilize
notebook

•

First Visit Implementation
BPA MDs
Entire BPA
Face to face patient time
BPA NPs
clinic
• Inhaler Technique
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Intervention
•
•
•
•
•
•
•
•

Inhaler technique
eval
Inhaler use
checklist
Inhaler technique
education
Competition
AAP
Asthma
education
handout
Review of ER
utilization
Review of
missed
school/work
Schedule 3
month follow up
visit

Evidence Support

Who

Where

BPA
nursing
BPA MAs
Hadley
Front Desk

How

•
•
•

•
•
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Patient inhaler technique evaluated by
nurses and recorded on Inhaler Use
Checklist. Occured after provider visit.
AAP filled out by provider
All forms filled out otherwise by
family/patients
All forms brought back to PD desk
(ownership: self-efficacy for treatment;
perception of health, perception of
abilities) 1-31
Inhaler technique hands-on and verbal
education provided by nursing to patients
Occured after provider visit.
Education discussed and reviewed per
protocol checklist
(ownership: self-efficacy for treatment;
perception of health, perception of
abilities) 1-31

•

ACT, QOL forms filled out by
patient/family before patient visit
Forms placed into project protocol binder
(ownership: self-efficacy, wellness,
perception of health, perception of
abilities)1-31

•

ER/urgent care utilization and missed
school days form reviewed by MA before
visit
Patient filled out reported form

Intervention

Evidence Support

Who

Where

How
Staff review Meditech reports
Form was given to provider for review
then placed into project binder
(ownership: wellness equates to all areas
of life- including school and socialization
and activities of daily living)1-31

•
•
•
•
•

ACT
Pediatric QOL
Inhaler technique
eval
Inhaler use
checklist
Inhaler technique
education

1-31

•

AAP completion
AAP was given to provider for
completion at time of patient visit
AAP copied and scanned into EMR
Verification form placed into project
binder
(ownership: self-efficacy, responsibility,
wellness) 1-31

•

Three month follow up visit tickler alert
filed
(Ownership: self-efficacy, responsibility)

Subsequent Asthma Visit Implementation Plan
BPA MDs
Entire BPA
• Face to face patient time
BPA NPs
clinic
• Outcome metrics as described in outcome
BPA
metric protocol
nursing
BPA MAs
• Inhaler Technique
Hadley
Patient inhaler technique evaluated by
Front Desk
nurses and recorded on Inhaler Use
Checklist after provider visit
Inhaler Use placed into project binder
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Intervention
•

•
•

•

Evidence Support

Who

Where

How
(ownership: self-efficacy for treatment;
perception of health, perception of
abilities) 1-26

Review AAP:
new plan
completed if new
medications
Review of ER
utilization
Review of
missed
school/work
(ownership:
wellness equates
to all areas of
life- including
school and
socialization and
activities of daily
living)
Schedule 3month f/u
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•

Inhaler technique hands-on and verbal
education provided by nursing to patients
after provider visit
Education discussed and reviewed per
protocol checklist
(ownership: self-efficacy for treatment;
perception of health, perception of
abilities) 1-31

•

ACT, QOL forms filled out by
patient/family before patient visit
Forms labeled and given to provider for
review
Forms placed into project protocol binder
(ownership: self-efficacy, wellness,
perception of health, perception of
abilities) 1-31

•

ER/urgent care utilization and missed
school days form before patient visit
Patient filled out reported form
Staff review of Meditech reports
Form was given to provider for review
then placed into project binder
(ownership: wellness equates to all areas
of life- including school and socialization
and activities of daily living) 1-31

Intervention

•
•
•
•

PDSA
8-dimension
Barriers
Facilitators

Sustainability
Financial Tracking

Evidence Support

Who

Where

Monthly QI/QA Assessment Plan
QI/QA processes
BPA MDs
CHP-BPA
improve EBP
BPA NPs
library
BPA
AHRQ: PDSA, 2017
nursing
IHI: PDSA 2017
BPA MAs
Reed & Carol, 2015
Hadley
Front Desk
ASQ: 8 dimensions
2017
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How
•

AAP completion
AAP was given to provider for
completion at time of patient visit
AAP copied and scanned into Athena
EMR
Verification form placed into project
binder
(ownership: self-efficacy, responsibility,
wellness) 1-31

•

Three months follow up visit tickler alert
filed
(Ownership: self-efficacy, responsibility)

•
•
•
•

Face face meeting
Whiteboard
Journaling by GMN
Notebook kept in library for project
comments, suggestions for improvement

•
•
•

Review of QI/QA measures
Discuss successes and barriers
Sustainability discussion- how to keep
project moving forward; move into other
CHP practices

Implementation Plan: developed through the Clinical Scholar EBP model
Table AC2: Progress Markers for Implementation of DNP Scholarly Program
Date
Progress
Evidence Who?
What?
Where?
Marker
11/1/17
IRB
CHP
IRB
CHP
decision
GMN

When?

How?

Final Outcome

11/1/17

Face to
face
discussion
Form
signature

11/6/17

Face to
face
discussion

No IRB required
for protocol
implementation
Verbal given for
project
implementation;
formal meeting to
be held April 2018.
Received approval
to implement
Clinic approval:
was an ongoing
process. Final clinic
approval discussed;
not all providers
agreeable to
proceed (7/18)
Cory from RT was
contacted. Have
met with CMOwill require CORI
background check,
confidentiality and
possible further
steps for her.
I met with her and
lead nurse at BMC
and discussed IT
6/18. She was not

11/6/17

CHP
approval

CHP
GMN

Approval

CHP

11/6/17

Clinic
discussion
project

GMN
Shalan

Discussion of roll
out of project

Shalan
office
BPA

11/13/17

Contact
with
respiratory
therapist
(RT)

GMN

RT to assist with
training/
Education of
inhaler technique

CHP-BPA 11/13/17 Email
contact

9,13,16
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Date

11/13/17

12/4/17

12/26/17

Progress
Marker

Evidence Who?

Contact
with
Roberta
Gale, NP:
head of ER
at BMC

Contact
with Joan
Roy nursing
director
Pittsfield
Public
Schools

Acquire
ACT, QOL,
AAP,

GMN
Roberta
Gale

1-26

1-26

GMN
Nursing
director

GMN
Review
Lamm,

What?

Where?

Internal data for
why ER utilized;
how many ER
visits occur

Discuss project;
discuss if
absenteeism data
can be shared or
if need IRB
(ownership:
wellness equates
to all areas of lifeincluding school
and socialization
and activities of
daily living)
Patient completed
(ethically to hear
their voice)
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When?

How?

CHP-BPA 11/13/17 Email
contact
rgale1@
bhs1.org

CHP-BPA

Email
contact
jroy@
Pittsfield.
Net

Final Outcome
EBP minded. I
contacted Fallon
ACO for RT
support; not able to
arrange in time of
implementation
Appt arranged
12/4/17; canceled
by Gale. Require
reschedule.
4/18:Ultimately
decided by PD and
CMO not to
procede. To obtain
data from Meditech
4/18: Decision
made to not move
forward; would
require an IRB.
Future work with
school consid

413-4999535
x2144

PDF
creation
of packets

12/26/17 PDF
creation

Completed 6/18:

Date

Progress
Marker
inhaler use
checklist,
create
patient
packets

Evidence Who?
Shalan and
nursing

What?

Where?

Inhaler checklistmetric form
Patient packets:
all metric forms

When?

Contact
asthma
coalition
for AAP,
ACT,
QOL,
inhaler
use

How?

Final Outcome

Phone and
email
contact
with
agencies

ACT: acquired
from Merck; no
copyright required
QOL: acquired
from Dr.
Copyright not allow
for import into
EMR or publication
to EPIP
AAP: acquired
from state of MA
Inhaler use
checklist: 8 inhaler
steps with yes/no
validation typed
onto single paper
ER/urgent care and
missed school days
form: form typed
by PD for clinic use

1/8/2018

Meeting
Shalan,
Lamm,
nursing,

GMN
Shalan
Lamm
Nursing

Discuss patient
flow,
appointments
Tickler alarm
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CHP-BPA 1/8/18

Face to
face
discussion

All packets created
by PD
complete: complete
with discussion and
with any change in
project plan

Date

1/8/2018

Progress
Marker
office
manager

Evidence Who?

Provider/
Nursing
progress
meeting

1/30/18

RT training
with
providers/
nursing

Where?

When?

How?

Hadley

Internal data
discussion

1/22/18

What?

GMN
Shalan
Lamm

BPA MDs
BPA NPs
BPA
nursing
Hadley

9,13,16

BPA MDs
BPA NPs
BPA
nursing

Final Outcome
tickler alarm to be
discussed

How to acquire
internal data
CHP-BPA

Discussion of
progress of
project; begin
discussion of
QI/QA,
sustainable
project
Evidence has
shown providers
require IT
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CHP-BPA 1/8/18

Face to
face
discussion

CHP-BPA 1/22/18
library

Face to
face
discussion

CHP-BPA 1/30/18
library
and

Face to
face
discussion

discussions
continued each
month; ending in
6/18 for preimplemenation
4/18: EMR not able
to have viable
asthma patient
report. Nursing
gave PD partial list
of asthma patients.
PD adding to every
day
Will have to hand
count asthma
patients for project
Monthly meetings
held April-August
2018 regarding
implementation

6/18: met with RT;
will not be ethical
to move forward

Date

Progress
Marker

Evidence Who?
RT

4/1/2018

Information
fliers sent to
patients

GMN
Hadley
Front Desk

Posters
placed in
waiting
room and
patient
rooms

4/9/2018

Meeting
with Dr
EFO for UT
Tyler sign
off
4/16/2018 Meeting
with
providers at
CHP-BPA

What?

Where?

training as well.
First RT meeting

provider
offices

Patient and
families to
become familiar
with new asthma
care format in
office

When?

CHP-BPA 4/1/18
Info sent
to family
homes

PD
EFO

Official
univeristy/advisor
sign off of project

Zoom
session

PD
NPs and
MDs

To discuss project
in detail and how
will affect
schedules and
providers

CHP-BPA Week of
4/16

150

4/9/18

How?

Final Outcome

Schedule
as needed
to meet
with all
provider
Nursing

since EBP not
embraced.

PD had inhaler
training then met
with each nurse and
taught. Providers
did not attend
trainings
Written
7/18: Met with
info
CMO to discuss.
One general
Poster info introduction to
asthma care form
written and added
to each asthma
packet.

Zoom

In person

At this time no
formal posters
printed
Received approval
to implement from
Dr EFO and UT
Tyler after 6/18
intensives in Tyler
7/18, 8/18: Met
with each provider
individually for
final implemtation.
Each provider

Date

Progress
Marker

7/5/2018

Launch of
project

7/5/2018

Provider/
Nursing/
Front desk
Meeting

11/1/18

Provider/
Nursing
meeting

11/1/18

Metric
analysis of
project
outcomes

Evidence Who?

1-26

All of BPA

BPA MDs
BPA NPs
BPA
nursing
BPA MAs
Hadley
Front desk
BPA MDs
BPA NPs
BPA
nursing
BPA MAs
Hadley
Front desk
GMN
Shalan
Lamm

What?

Where?

When?

How?

Final Outcome
voiced concerns. 1
provider opted out
of program; 1
provider only
allowed well care
visits
Project launded
7/5/2018 with final
day 10/19/2018
data collection

Launch of EBP
project at BPA
Start of metric
collection
QI/QA
Status review of
week 1 of roll out
Barriers
Facilitators
First QI/QA eval

CHP-BPA 7/5/2018 Clinicbased

CHP-BPA 7/5/2018 Face to
library
face
discussion

Weekly meetings
with nursing and
MAs: discussed
successes/failures.
Occurred
throughout project

Debrief of project
Barriers
Facilitators
QI/QA
How to keep
sustain care

CHP-BPA 11/1/18
library

Face to
face
discussion

Start of analysis
of metrics,
outcomes, QI/QA

CHPlibrary

Face to
face
discussion

Debriefing
regarding
implementation
occurred with full
team. Start of data
review and
dissemnation
process began
Face to face
discussion
occurred; zoom
meeting with Dr
Lamm and Dr EFO
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11/1/18

Date

7/20185/2019

Progress
Marker

Disseminate
project

Evidence Who?

GMN
Lamm
Shalan
UT Tyler
faculty

What?

Where?

Metric analysis
Scholarly write
up of project
Send for
publication
National
conference

GMN
home
GMN
BPA

When?

How?

Face to
face
discussion
Phone
Email
US Mail
Attend
national
conference:
podium
and poster
present

Final Outcome
11/8/18 for
discussion of
project
Presented poster
presentation (up to
implementation) at
Doctors of Nursing
Practice
Conference, Palm
Springs, Sept 2018
Ownership of
Adolescent Ashtma
Health: A Concept
Analysis: Published
Nursing Forum
December 2018
Abstract Submitted
for EPIP
presentation at
Sigma Theta Tau
Nov 2019
conference
Post presentation;
written manuscript
to be published
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Appendix D: Forms

THE UNIVERSITY OF TEXAS AT TYLER COLLEGE OF NURSING AND HEALTH SCIENCES
SCHOOL OF NURSING – DOCTOR OF NURSING PRACTICE PROGRAM. DNP MENTOR AGREEMENT
I have reviewed the mentor guidelines. I can provide the student with advanced experiences
that meet the DNP Scholarly Project (EPIP) goals as agreed upon by the student, the faculty
mentor, and me. I understand that there will be no remuneration for this service. I will
facilitate and review the student’s learning activities and will submit the required evaluations
to the DNP Program.
I Evere_t_t _L_a_mm_,_MD_,_F_AA_P
to serve as a (name of mentor)

agree

mentor for the DNP student G_i_n_a_Nic_k_e_l_s-_Ne_ls_o_n
(name of student)

from
to
mentorship) (anticipated end of mentorship)

(beginning date of

OR
I agree to mentor for the following semesters: All Semesters ☐
OR
Specifically:

Fall

Spring

Summer I

May UTTYLER disclose your contact information for future students seeking mentors?
y
es or
no

Date 9_/5_/_2_0_1_7_

Mentor Signature
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For office use only:
Reviewed by

Date

Approved as a DNP mentor

yes

no

COLLEGE OF NURSING AND HEALTH SCIENCES
SCHOOL OF NURSING – DOCTOR OF NURSING PRACTICE PROGRAM
Mentor Biographical Data
(Please note that an updated resume or curriculum vitae may be submitted as an alternate to
the completion of this section)
Name:

E
__ve_r_e_t_t _L_a_m
_m,_MD_,_F_AA_P

Current Agency C_o_m
Position or Title:

mu_n_it_y_He_a_lt_h_P
_r_o_g_r_a_ms_, _In_c_.
C_h_ie
_f M_e_d_i_c_a_l _O_f_fi_c_e_r

Office Address: 4_4_4 S_t_o_c_k_b_ri_d_g_e R_o_a_d_,_Gre_a_t B_a_r_ri_n_g_to_n_,_MA 0_1_2_3_0
(street)
(city) (state) (zip)

Office phone with area code _4_1_3_-_5_2_8_-_9_3_1_1 x_1_1_4_3
Fax number
Email (personal or office)

e_l_a_m_m@c_h_p_b_e_r_k_s_h_ir_e_s_.o_r_g

Alternate email
Preferred Method of Contact:

X Email

Phone

Type of position you currently hold C_h_ie
__f _M_e_d_i_c_a_l _O_f_fi_c_e_r
rural health site?

X yes

Designated

no

Designated health professional shortage area?
Designated medically
underserved area?

X

yes

no
X
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yes

no
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Education
Undergraduate Degree
1. U_n_iv_e_r_s_it_y o_f _P_e_n_n_s_y_lv_a_nia_,_P_h_i_la_d_elp_h_ia, _P_A_,_BA_/'_9_2
(Name of institution) (City/State) (Degree/Year)

2. Ha_rv_a_r_d U_n_iv_e_r_s_it_y_,_C_a_mb_r_id_g_e_,_MA_,_Po_s_t-_B_a_c_c_a_l_a_u_re_ate P_r_e_m_e_d_i_c_a_l
_S_t_udies/'93 (Name of institution) (City/State) (Degree/Year)

Graduate Degree
1. Un_iv_e_r_s_it_y_o_f_Ve_rmo_n_t_C_o_l_le_g_e o_f_Me_d_ic_i_n_e_,_B_u_r_li_n_g_ton_, _V_T_,_M
D_/_'9_9
institution) (City/State) (Degree/Year)

(Name of

Postgraduate Specialty Training
1._Uni_v_e_rs_i_ty_o_f_Ve_rmo_n_t _C_o_ll_e_ge o_f _M_e_d_i_c_in_e_, _B_u_r_lin_g_t_o_n_, _V_T_,_P_e_d_i_a_tr_ic_Re_s_id_e_n_c_y_Program 19992002

(Name of institution) (City/State) (Degree/Year)
2.
institution) (City/State) (Degree/Year)

(Name of

License Information (*Must provide State verification/proof of licensure and
certification when applicable)

Professional License Number/State _2_6_9_0_2_4_/_M_a_s_s_a_c_h_u
sett_s
Board Certification: X

yes no

Certifying Board (if applicable):
1._Am_e_r_ic_a_n B_o_a_r_d o_f _P_e_d_iatr_ic_s

Date 2_0_0_3

2.

Date

Employment Last Five Years (most recent first)

Employer City/State Dates
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1. C_o_mmu_n_it_y_He_a_lt_h_P_r_o_g_r_a_ms, In_c_. G_r_e_a_t_B_a_r_r_in_g_t_o_n_,_M
ia_n_s_,_L_L_C, _E_x_e_t_e_r,_NH 8_/2_0_0_9
A_9_/_2_0_1_6_-_P_r_e_s_e_n_t 2. Co_re P_h_y_s_i_c_
_8
/
2
0
1
6
______
3.
4.

Student Signature: Gina M Nickels-Nelson

Date submitted: 9-6-2017

Form AD1: Memorandum of Understanding: Industry Mentor Agreement
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*/

CHP Berkshire Pediatrics is introducing a new asthma care program for your
child/teen. Your child’s health, especially caring for asthma, is extremely
important to us. So, over the next few months we will begin implementing
additional care measures at our office that you will notice.
At your visits, there will be new paperwork we are requesting you to fill out
regarding how asthma is affecting your life at home. Asthma not only causes
breathing issues, but can also cause your child to miss school and for you to
miss work. By filling out these questions, we will better be able to address these
issues.
We are also going to have your child show us how they use their inhaler at home.
Please bring your medication and spacer to the office for each visit. Even though
most people believe they use their medication correctly, unfortunately only about
40% of patients use their inhaler appropriately. This is usually as a result of not
getting the proper training when the diagnosis is made. If your child is not using
their medication correctly, then they are not getting the medication to their lungs
to help manage their asthma effectively.
These are the first steps to improving your child’s care. We look forward to
seeing you and your child in our office every 6 (six) months to make sure your
child is doing well and not suffering as a result of having asthma.
Form AD2: Patient Introduction Letter to Project
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Form AD3: Asthma Control Test
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Form AD4: Asthma Control Test
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Form AD5: Asthma Action Plan
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MDI Inhaler Use Checklist Evaluation Form

Name of Patient:

Date of Evaluation:

Evaluator:

MDI Step

Score

Remove Cap
Shake inhaler/place
into spacer
Exhale completely
Place mouthpiece
in mouth between
lips
Press canister down
once
Inhale slowly and
deeply; hold breath
10 seconds
Breathe out gently
Wait 30 seconds
before next dose

1
1

Pre-Education
Score

1
1

1
1

1
1
Form AD6: Inhaler Technique Checklist
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Post Education
Score

